for definitions of bleeding, score and inclusion/exclusion ... table individual 2018.pdfactinomycin...

48
Single Report Database for Drug-Induced Thrombocytopenia: An Update 2018 For definitions of bleeding, score and inclusion/exclusion criteria, click here. HOS = Hospitalized, BL = Bleeding, SC = Score, EX = Exclusion, NR = Not Recorded, NA = Not Applicable DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018 ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 64 YRS M NR YES 3 2 NA NO ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 70 YRS M NR YES 2 3 NA NO ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 42 YRS M NR YES 2 3 NA NO ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 59 YRS F NR YES 3 3 NA NO ABCIXIMAB CIRCULATION 95:809-813 1997 53 YRS M NR NO NR 3 NA NO ABCIXIMAB CIRCULATION 95:809-813 1997 49 YRS F NR NO NR 3 NA NO ABCIXIMAB CIRCULATION 95:809-813 1997 83 YRS M NR NO NR 3 NA NO ABCIXIMAB CIRCULATION 95:809-813 1997 62 YRS M NR NO NR 3 NA NO ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR M NR NO NR 5 1 NO ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR F NR NO NR 5 1 NO ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR M NR NO NR 5 1 NO ABCIXIMAB CIRCULATION 97:1214-1215 1998 62 YRS M NO YES NR 3 NA NO ABCIXIMAB CLIN CARDIOL 21:851-852 1998 82 YRS M NO YES NR 3 NA NO ABCIXIMAB LANCET 352:1312 1998 63 YRS M NO YES NR 3 NA NO ABCIXIMAB J AM COLL CARDIOL 32:311-319 1998 NR NR NR NO NR 5 1 NO ABCIXIMAB AM J HEMATOL 61:205-208 1999 55 YRS M NR NO NR 3 NA NO ABCIXIMAB AM J HEMATOL 61:205-208 1999 51 YRS M NR NO NR 3 NA NO ABCIXIMAB AM J HEMATOL 61:205-208 1999 48 YRS M NR NO NR 3 NA NO ABCIXIMAB J INVASIVE CARDIOL 11:313-315 1999 75 YRS M NR NO NR 3 NA NO ABCIXIMAB LANCET 353: 1185 1999 63 YRS F NR NR NR 5 2 NO ABCIXIMAB J INVASIVE CARDIOL 12:109-112 2000 52 YRS M NO YES 0 2 NA NO ABCIXIMAB J INVASIVE CARDIOL 12:528 2000 80 YRS F NO YES 0 2 NA NO ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

Upload: others

Post on 24-Mar-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

Single Report Database for Drug-Induced Thrombocytopenia: An Update 2018

For definitions of bleeding, score and inclusion/exclusion criteria, click here.

HOS = Hospitalized, BL = Bleeding, SC = Score, EX = Exclusion, NR = Not Recorded, NA = Not Applicable

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 64 YRS M NR YES 3 2 NA NO

ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 70 YRS M NR YES 2 3 NA NO

ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 42 YRS M NR YES 2 3 NA NO

ABCIXIMAB AM J CARDIOL 78:1161-1163 1996 59 YRS F NR YES 3 3 NA NO

ABCIXIMAB CIRCULATION 95:809-813 1997 53 YRS M NR NO NR 3 NA NO

ABCIXIMAB CIRCULATION 95:809-813 1997 49 YRS F NR NO NR 3 NA NO

ABCIXIMAB CIRCULATION 95:809-813 1997 83 YRS M NR NO NR 3 NA NO

ABCIXIMAB CIRCULATION 95:809-813 1997 62 YRS M NR NO NR 3 NA NO

ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR M NR NO NR 5 1 NO

ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR F NR NO NR 5 1 NO

ABCIXIMAB CIRCULATION 96:3809-3810 1997 NR M NR NO NR 5 1 NO

ABCIXIMAB CIRCULATION 97:1214-1215 1998 62 YRS M NO YES NR 3 NA NO

ABCIXIMAB CLIN CARDIOL 21:851-852 1998 82 YRS M NO YES NR 3 NA NO

ABCIXIMAB LANCET 352:1312 1998 63 YRS M NO YES NR 3 NA NO

ABCIXIMAB J AM COLL CARDIOL 32:311-319 1998 NR NR NR NO NR 5 1 NO

ABCIXIMAB AM J HEMATOL 61:205-208 1999 55 YRS M NR NO NR 3 NA NO

ABCIXIMAB AM J HEMATOL 61:205-208 1999 51 YRS M NR NO NR 3 NA NO

ABCIXIMAB AM J HEMATOL 61:205-208 1999 48 YRS M NR NO NR 3 NA NO

ABCIXIMAB J INVASIVE CARDIOL 11:313-315 1999 75 YRS M NR NO NR 3 NA NO

ABCIXIMAB LANCET 353: 1185 1999 63 YRS F NR NR NR 5 2 NO

ABCIXIMAB J INVASIVE CARDIOL 12:109-112 2000 52 YRS M NO YES 0 2 NA NO

ABCIXIMAB J INVASIVE CARDIOL 12:528 2000 80 YRS F NO YES 0 2 NA NO

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

Page 2: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

ABCIXIMAB AM J CARDIOL 85:435 2000 NR NR NR NO NR 3 NA NO

ABCIXIMAB HEART 83:E5 2000 64 YRS M NO YES 0 3 NA NO

ABCIXIMAB N Z MED J 113:86 2000 56 YRS M NR NO NR 3 NA NO

ABCIXIMAB ANN PHARMACOTHER 34:924 2000 71 YRS m NR NO NR 4 NA NO

ABCIXIMAB CATHETER CARDIOVASC INTERV 49:177-180 2000 56 YRS F YES YES 3 4 NA NO

ABCIXIMAB AM HEART J 140:74 2000 NR NR NR NO NR 5 1 NO

ABCIXIMAB CATHETER CARDIOVASC INTERV 52:468 2001 75 YRS F NO YES 0 3 NA NO

ABCIXIMAB HAEMATOLOGICA 86:E07 2001 82 YRS M NO YES 0 3 NA NO

ABCIXIMAB J INVASIVE CARDIOL 13:56 2001 52 YRS F NR NO NR 3 NA NO

ABCIXIMAB CARDIOLOGY 95:215-216 2001 55 YRS M NR NO NR 4 NA NO

ABCIXIMAB CARDIOLOGY 95:215-216 2001 51 YRS M NR NO NR 4 NA NO

ABCIXIMAB HEART 86:E18 2001 68 YRS M YES NO 2 4 NA NO

ABCIXIMAB J INV CARDIO 13:56-8 2001 52 YRS F NO NO 0 4 NA NO

ABCIXIMAB CATH & CARDIOVASC INTERV 53:225-8 2001 NR NR NR NR NR 5 2 NO

ABCIXIMAB NEJM 344:1888-1894 2001 NR NR NR NO NR 5 1 NO

ABCIXIMAB J CARDIOVASC PHARMACOL THER 7:21-24 2002 65 YRS F NO YES 1 2 NA NO

ABCIXIMAB QJ MED 95:635-638 2002 55 YRS M NO YES 1 3 NA NO

ABCIXIMAB J INVASIVE CARDIOL 16: 537-538 2004 75 YRS M NO YES NR 1 NA NO

ABCIXIMAB HEART 90:E55 2004 44 YRS F NO YES 3 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 71 YRS M NR YES 1 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 71 YRS F NR YES 1 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 72 YRS M NR YES 3 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 72 YRS M NR NO 1 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 55 YRS M NR YES 0 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 60 YRS F NR YES 1 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 61 YRS M NR YES 0 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 67 YRS F NR YES 2 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 79 YRS M NR YES 1 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 67 YRS F NR YES 3 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 57 YRS M NR YES 3 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 63 YRS M NR YES 2 3 NA NO

ABCIXIMAB J THROMB HAEMOST 2:985-992 2004 74 YRS F NR YES 0 3 NA NO

Page 3: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

ABCIXIMAB ITAL HEART J 6:647-651 2005 53 YRS M NO YES 0 3 NA NO

ABCIXIMAB ITAL HEART J 6:647-651 2005 47 YRS M NO YES 0 3 NA NO

ABCIXIMAB J INVASIVE CARDIOL 18: E173-E174 2006 43 YRS M NR YES 3 5 1 NO

ABCIXIMAB PHARMACOTHERAPY 26:423-427 2006 62 YRS M NR NO NR 5 1 NO

ABCIXIMAB J THROMB THROMBOLYSIS 24:59-64 2007 59 YRS M NR YES 0 2 NA NO

ABCIXIMAB J THROMB THROMBOLYSIS 24:59-64 2007 51 YRS M NO YES 0 3 NA NO

ABCIXIMAB J INTERV CARDIOL 21:100-5 2008 64 YRS M NO YES 3 2 NA NO

ABCIXIMAB THROMB HAEMOST 103:484-6 2010 NR NR NR NR NR 5 1 NO

ABCIXIMAB PLATELETS 22:302-4 2011 77 YRS M NO YES NR 3 NA NO

ACECLOFENAC INT J DERMATOL 54:819-22 2015 44 YRS F NO NR NR 1 NA YES

ACETAMINOPHEN BMJ 3:743-374 1968 63 YRS F NO NO 1 1 NA NO

ACETAMINOPHEN NEJM 287:376-381 1972 22 YRS M NR YES NR 3 NA NO

ACETAMINOPHEN CLEVE CLIN Q 40: 89-91 1973 61 YRS M NO YES 3 2 NA NO

ACETAMINOPHEN LANCET 2:1159 1978 30 YRS M NO YES 2 1 NA NO

ACETAMINOPHEN NEJM 300:678 1979 29 YRS M NR NO NR 3 NA NO

ACETAMINOPHEN NEJM 303:47 1980 70 YRS M NO NO 1 1 NA NO

ACETAMINOPHEN ANN INTERN MED 95:783 1981 80 YRS M NO YES 3 2 NA NO

ACETAMINOPHEN BLOOD 97:3846 2001 66 YRS F NR NO NR 2 NA NO

ACETAMINOPHEN BLOOD 97:3846 2001 30 YRS M NR NO NR 2 NA NO

ACETAMINOPHEN BLOOD 109:3608-9 2007 4 YRS F NO YES 2 1 NA NO

ACETAZOLAMIDE JAMA 160:206-207 1956 85 YRS M NO YES 3 2 NA NO

ACETAZOLAMIDE ARCH INTERN MED 99:1006 1957 61 YRS M NO NO NR 2 NA NO

ACETAZOLAMIDE ARCH INTERN MED 99:1000 1957 61 YRS M NR YES NR 4 NA NO

ACETAZOLAMIDE BMJ 1:1338 1958 69 YRS F NR NR NR 4 NA NO

ACETAZOLAMIDE AM J OPHTHALMOL 100:79-81 1985 NR NR NR NO NR 5 1 NO

ACETAZOLAMIDE ARCH OPHTHALMOL 122:1543-1544 2004 67 YRS M NO YES 0 1 NA NO

ACTINOMYCIN D AM J THER 23:E594-6 2016 3.5 YRS F NO YES NR 5 3 YES

ACYCLOVIR AM J EMERG MED 16:396-398 1998 8 YRS M NR NO NR 5 2 NO

ACYCLOVIR PHARMACOTHERAPY 30:1089-93 2010 20 YRS M NO YES 0 2 NA NO

ADALIMUMAB GUT 56:1169-70 2007 42 YRS F NO NO 0 3 NA NO

ADALIMUMAB J CROHNS COLITIS 6:1034-7 2012 71 YRS F NR NR NR 4 NA NO

ADALIMUMAB INT J PHARM PHARM SCI 7:456-8 2015 26 YRS M NO YES 1 2 NA YES

ADEFOVIR DIG LIVER DIS 38:211-212 2006 56 YRS M NO YES NR 1 NA NO

Page 4: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

AGOMELATINE THERAPIE 72:401-2 2017 60 YRS F YES NR 2 3 NA YES

ALATROFLOXACIN ANN PHARMACOTHER 34:330 2000 54 YRS F NO YES 2 2 NA NO

ALBENDAZOLE ANN PHARMACOTHER 32:842 1998 25 YRS F NO YES 2 2 NA NO

ALFUZOSIN ARCH ITAL UROL ANDROL 82:195-7 2010 65 YRS M NO NO 0 1 NA NO

ALLOPURINOL MED J AUST 2:468 1973 86 YRS F NR NO NR 5 1 NO

ALLOPURINOL JAMA 227:1036 1974 NR NR NR NO NR 5 1 NO

ALLOPURINOL DICP 15:286-287 1981 NR NR NR NO NR 5 2 NO

ALPRENOLOL ACTA MED SCAND 207:231-233 1980 65 YRS F NO YES 2 1 NA NO

AMINOGLUTETHIMIDE CANCER TREATMENT REPORTS 66:1785-1786 1982 58 YRS F NO YES 0 1 NA NO

AMINOGLUTETHIMIDE CANCER TREATMENT REPORTS 67:849 1983 47 YRS F NR YES NR 4 NA NO

AMINOGLUTETHIMIDE CANCER TREATMENT REPORTS 68:1015-1016 1984 53 YRS F NO YES 3 1 NA NO

AMINOGLUTETHIMIDE CONN MED 48:423-424 1984 63 YRS F NO NO 2 2 NA NO

AMINOGLUTETHIMIDE TUMORI 76:511-512 1990 49 YRS F NR YES NR 3 NA NO

AMINOSALICYLIC ACID JAMA 153:1094 1953 18 YRS F NO NO 3 1 NA NO

AMINOSALICYLIC ACID DIS CHEST 23:645-656 1953 49 YRS M NO YES 0 3 NA NO

AMINOSALICYLIC ACID JAMA 172:1909 1960 63 YRS M NO YES 2 1 NA NO

AMINOSALICYLIC ACID AM J MED 53:790-796 1972 45 YRS M NO YES 1 2 NA NO

AMINOSALICYLIC ACID J PEDIATR 83:502-503 1973 8 MOS M NO YES 2 1 NA NO

AMIODARONE ARCH INTERN MED 147:735-736 1987 45 YRS M NO YES 1 1 NA NO

AMIODARONE ARCH INTERN MED 147:735-736 1987 69 YRS M NO YES 1 1 NA NO

AMIODARONE BR J HAEMATOL 163: 260-7 2013 NR NR NR NR NR 3 NA NO

AMIODARONE BR. J. HAEMATOL 163: 260-7 2013 63 YRS F NR NR NR 3 NA NO

AMIODARONE BR. J. HAEMATOL 163: 260-7 2013 49 YRS M NR NR NR 3 NA NO

AMIODARONE BR. J. HAEMATOL 163: 260-7 2013 77 YRS F NR NR NR 3 NA NO

AMITRIPTYLINE AM J HEMATOL 53:49-50 1996 68 YRS F NR NO NR 3 NA NO

AMLODIPINE ANN PHARMACOTHER 33:1126 1999 34 YRS F NO NO 3 2 NA NO

AMLODIPINE VOX SANG 86: 75-6 2004 79 YRS M NR NR NR 4 NA NO

AMLODIPINE J CLIN PHARM THER 38: 246-8 2013 78 YRS F NO YES 2 1 NA NO

AMOXICILLIAN THERAPIE 68: 171-2 2013 40 YRS M NR NR NR 5 1 NO

AMPHOTERICIN B ANN INTERN MED 96:332-333 1982 48 YRS M NO YES 0 1 NA NO

AMPHOTERICIN B JAPI 38:235-236 1990 37 YRS M NO YES 0 1 NA NO

AMPHOTERICIN B JAPI 38:235-236 1990 20 YRS M NO YES 0 2 NA NO

AMPICILLIN MED J AUST 1:435 1972 NR NR NR NO NR 5 1 NO

Page 5: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

AMPICILLIN LANCET 2:723 1974 69 YRS F NO YES 3 2 NA NO

AMPICILLIN ACTA HAEMATOL 67:71 1982 80 YRS F NR NO NR 4 NA NO

AMPICILLIN ANN INTERN MED 99:573 1983 30 YRS F NO YES 2 2 NA NO

AMPICILLIN UROL INT 42:313-315 1987 60 YRS F NO YES 2 2 NA NO

ANAGRELIDE BLOOD 79:1931-1937 1992 NR NR NR NO NR 5 1 NO

ANAGRELIDE PHARMACOTHERAPY 18:822-826 1997 43 YRS F NO YES NR 5 3 NO

ANAGRELIDE AM J HEALTH-SYST PHARM 55:1979-1986 1998 NR NR NR NO NR 5 1,3 NO

ANAKINRA J RHEUM 45:1313-4 2006 57 YRS M NO NO 0 2 NA NO

ANTINEOPLASTIC AGENTS J ONCOL PHARM PRACT 23:135-42 2017 NR NR NR NR NR 5 1, 3 YES

ASPARTAME SOUTH MED J 100:543 2007 NR F NR NO NR 5 1 NO

ASPARTAME SOUTH MED J 100:543 2007 10 YRS F NR NO NR 5 1 NO

ASPARTAME SOUTH MED J 100:543 2007 11 YRS F YES NO NR 5 1 NO

ASPARTAME SOUTH MED J 100:543 2007 61 YRS M NO NO NR 5 1 NO

ASPIRIN AM J MED SCI 267:129-132 1974 75 YRS M NO YES 1 2 NA NO

ASPIRIN BR J PHARMACOL 60:292P-293P 1977 NR NR NR NO NR 5 1 NO

ASPIRIN NEJM 300:678 1979 29 YRS M NR NO NR 3 NA NO

ASPIRIN INT J CLIN PHARMACOL THER 51: 228-231 2013 73 YRS F NR NR NR 4 NA NO

ATORVASTATIN LANCET 352:1284 1998 46 YRS M NO YES 1 1 NA NO

BAJIAOLIAN HUM EXP TOXICOL 11: 480-487 1992 38 YRS M NO NO NR 3 NA NO

BAJIAOLIAN HUM EXP TOXICOL 11: 480-487 1992 55 YRS F NR NR NR 5 1 NO

BAJIAOLIAN HUM EXP TOXICOL 11: 480-487 1992 56 YRS M NR NR NR 5 1 NO

BAJIAOLIAN HUM EXP TOXICOL 11: 480-487 1992 39 YRS F NR NR NR 5 1 NO

BENZTROPINE PSYCHOSOMATICS 41:277 2000 38 YRS F NO YES 0 4 NA NO

BISMUTH GUT 30:1016 1989 72 YRS M NO YES 2 2 NA NO

BISOPROLOL J CLIN PHARM THER 43:280-3 2018 52 YRS M NR NR NR 1 NA YES

BLEOMYCIN EUR J CANCER 14:1261-1264 1978 NR NR NR NO NR 3 NA NO

BLEOMYCIN EUR J CANCER 14:1261-1264 1978 NR NR NR NO NR 3 NA NO

BLEOMYCIN EUR J CANCER 14:1261-1264 1978 NR NR NR NO NR 3 NA NO

BLEOMYCIN EUR J CANCER 14:1261-1264 1978 NR NR NR NO NR 3 NA NO

BLEOMYCIN EUR J CANCER 14:1261-1264 1978 NR NR NR NO NR 3 NA NO

BLEOMYCIN EUR J CANCER CLIN ONCOL 19:867 1983 NR NR NR NO NR 5 3 NO

BLEOMYCIN NETH J MED 27:202-205 1984 NR NR NR NO NR 5 3 NO

BORTEZOMIB PHARMACOTHERAPY 30:661-5 2010 NR NR NR NR NR 5 3 NO

Page 6: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

BORTEZOMIB BJMP 6:A631 2013 58 YRS F NR NR NR 5 3 NO

BROMOCRIPTINE AM J MED SCI 281:169-172 1981 NR NR NR NO NR 5 2 NO

BUMETANIDE POSTGRAD MED J 51:51-52 1975 NR NR NR NO NR 5 1 NO

BUTOBARBITAL BMJ 2:919 1957 65 YRS M NR YES NR 3 NA NO

BUTOCONAZOLE DICP 24:143-144 1990 54 YRS F NO YES 3 2 NA NO

CAPTOPRIL IR MED J 79:43-44 1986 68 YRS M NR YES NR 3 NA NO

CAPTOPRIL IR MED J 80:101 1987 70 YRS M NO YES 0 2 NA NO

CAPTOPRIL SINGAPORE MED J 29:526-527 1988 62 YRS M NR YES NR 5 1,7 NO

CAPTOPRIL BMJ 298:189-190 1989 75 YRS F NO YES 1 2 NA NO

CAPTOPRIL VOX SANG 57:218 1989 NR NR NR NO NR 5 1 NO

CARBAMAZEPINE LANCET 2:223 1968 79 YRS F NO YES 0 2 NA NO

CARBAMAZEPINE LANCET 2:223 1968 79 YRS F NR YES NR 3 NA NO

CARBAMAZEPINE HEADACHE 9:77 1969 NR NR NR NO NR 5 1 NO

CARBAMAZEPINE HEADACHE 9:88 1969 NR NR NR NO NR 5 1 NO

CARBAMAZEPINE AM J MED SCI 262:68-78 1971 49 YRS F NR NO NR 2 NA NO

CARBAMAZEPINE ANN NEUROL 3:373 1978 16 YRS F NO NO 0 2 NA NO

CARBAMAZEPINE ACTA HAEMATOL 68:68-70 1982 15 YRS M NO YES 2 2 NA NO

CARBAMAZEPINE ACTA HAEMATOL 68:74 1982 31 YRS F NO YES 1 2 NA NO

CARBAMAZEPINE ANN NEUROL 11:309-12 1982 16 YRS F NR NR NR 5 1 NO

CARBAMAZEPINE JAMA 250:2843-2844 1983 27 YRS M NO NO 0 2 NA NO

CARBAMAZEPINE DICP 17:642-644 1983 33 YRS F NR YES NR 3 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 45:315-316 1984 66 YRS F NO YES 1 2 NA NO

CARBAMAZEPINE CLIN PHARM 4:221-223 1985 4 YRS F NO YES 0 2 NA NO

CARBAMAZEPINE AM J PSYCHIATRY 145:1034 1988 18 YRS M NO NO 0 2 NA NO

CARBAMAZEPINE AM J PSYCHIATRY 145:1054 1988 18 YRS M NO YES 0 2 NA NO

CARBAMAZEPINE ACTA HAEMATOL 80:54-58 1988 63 YRS F NR NO NR 4 NA NO

CARBAMAZEPINE J CLIN PSYCHOPHARMACOL 10:305 1990 57 YRS M NR YES NR 4 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 52:496-498 1991 47 YRS M NO YES 1 2 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 52:496-498 1991 20 YRS M NR YES NR 3 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 52:496-498 1991 29 YRS M NR YES NR 3 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 52:496-498 1991 18 YRS F NR YES NR 3 NA NO

CARBAMAZEPINE ANN PHARMACOTHER 26:715-716 1992 8 YRS F NO NR 0 1 NA NO

CARBAMAZEPINE J CLIN PSYCHIATRY 53:378 1992 40 YRS F NO NO 1 2 NA NO

Page 7: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

CARBAMAZEPINE EUR J PEDIATR 152:769-770 1993 10 YRS F NO YES NR 2 NA NO

CARBAMAZEPINE VOX SANG 65:328-330 1993 38 YRS F NR NO NR 3 NA NO

CARBAMAZEPINE PSYCHIATRY CLIN NEUROSCI 49:69-70 1995 23 YRS F NO YES 0 2 NA NO

CARBAMAZEPINE ACTA HAEMATOL 100:104-105 1998 12 YRS F NO YES 0 2 NA NO

CARBAMAZEPINE ANN PHARMACOTHER 32:884-887 1998 69 YRS F NO YES NR 4 NA NO

CARBAMAZEPINE AM J EMERG MED 16:396-398 1998 8 YRS M NR NO NR 5 2,7 NO

CARBAMAZEPINE AM J HEMATOL 62:52-55 1999 12 YRS M NO YES 2 1 NA NO

CARBAMAZEPINE PSYCHIATRY CLIN NEUROSCI 55:423 2001 67 YRS F NO YES 0 3 NA NO

CARBAMAZEPINE NEUROL INDIA 51:132-133 2003 10 YRS M NO YES 2 2 NA NO

CARBAMAZEPINE BLOOD CELLS MOL DIS 48:197-8 2012 17 YRS F NO YES 0 1 NA NO

CARBAMAZEPINE BLOOD CELLS MOL DIS 59:97-9 2016 9 YRS F NO YES 2 2 NA YES

CARBOPLATIN CANCER INVEST 9:263-268 1991 NR NR NR NO NR 5 3 NO

CARVEDILOL AM J HEALTH-SYST PHARM 70:598-602 2013 64 YRS F NO YES 0 2 NA NO

CASPOFUNGIN PHARMACOTHERAPY 24:1408-1411 2004 68 YRS F NO YES 3 3 NA NO

CEFAMANDOLE J CLIN PATHOL 40:700-701 1987 69 YRS M NO YES 1 2 NA NO

CEFAZOLIN MIL MED 177:35-4 2012 21 YRS M NR NR NR 5 7 NO

CEFOTETAN BR J HAEMATOL 70:423-426 1988 86 YRS F NR YES NR 3 NA NO

CEFOTETAN TRANSFUSION 28:322 1988 NR NR NR NO NR 5 1 NO

CEFTAZIDIME DICP 25:135-136 1991 82 YRS F NR YES NR 3 NA NO

CEFTRIAXONE DICP 25:135-136 1991 82 YRS F NR YES NR 3 NA NO

CEFTRIAXONE TRANSFUSION 44: 1033-1040 2004 9 YRS M NO YES 0 2 NA NO

CEFTRIAXONE TRANSFUSION 44: 1033-1040 2004 66 YRS NR NR NO NR 3 NA NO

CEFTRIAXONE ANN HEMATOL 89:825-6 2010 69 YRS F NO YES 2 5 1 NO

CEFTRIAXONE BRATISL LEK LISTY 112:97-8 2011 2 YRS F NO YES 0 2 NA NO

CEFTRIAXONE TRANSFUSION 53: 2715-20 2013 65 YRS F NR NR NR 3 NA NO

CEFUROXIME POSTGRAD MED J 72:757-758 1996 77 YRS M NR YES NR 3 NA NO

CHEMOTHERAPY IN VIVO 31:439-41 2017 77 YRS F NR NR NR 5 3 YES

CHINESE HERBAL MEDICINE EMERGENCY MED AUSTRALASIA 16: 400-406 2004 NR NR NR NR 2 5 1 NO

CHLORAMPHENICOL ANN TROP PAEDIATR 18:123-128 1998 NR NR NR NO NR 5 1,7 NO

CHLOROTHIAZIDE BMJ 1:1338 1958 70 YRS M NR NO NR 4 NA NO

CHLOROTHIAZIDE JAMA 168:2264-2265 1958 70 YRS M NR YES NR 5 1 NO

CHLOROTHIAZIDE JAMA 168:2264-2265 1958 66 YRS M NR YES NR 5 1 NO

CHLOROTHIAZIDE LANCET 1:271-272 1959 51 YRS F NO NO 2 1 NA NO

Page 8: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

CHLOROTHIAZIDE LANCET 1:271-272 1959 51 YRS F NO NO 1 2 NA NO

CHLOROTHIAZIDE LANCET 1:271-272 1959 84 YRS M NR NO NR 3 NA NO

CHLOROTHIAZIDE LANCET 1:271-272 1959 63 YRS F NR NO NR 3 NA NO

CHLOROTHIAZIDE LANCET 1:271-272 1959 48 YRS F NR NO NR 4 NA NO

CHLOROTHIAZIDE LANCET 1:271-272 1959 76 YRS F NR NO NR 4 NA NO

CHLOROTHIAZIDE N Y STATE J MED 59:1117-1118 1959 58 YRS F NR NO NR 5 2 NO

CHLOROTHIAZIDE JAMA 173:663-665 1960 66 YRS F NO NO 1 2 NA NO

CHLOROTHIAZIDE JAMA 173:663-665 1960 63 YRS F NR NO NR 5 2 NO

CHLOROTHIAZIDE JAMA 173:663-665 1960 79 YRS F NR NO NR 5 2 NO

CHLOROTHIAZIDE PRACTITIONER 192:403 1964 NR NR NR NO NR 5 2 NO

CHLOROTHIAZIDE ACTA MED SCAND 183:245 1968 NR NR NR NO NR 5 1 NO

CHLOROTHIAZIDE AM J MED SCI 262:68-78 1971 62 YRS M NR NO NR 2 NA NO

CHLOROTHIAZIDE AM J MED SCI 262:68-78 1971 NEONATE M NR NO NR 5 1 NO

CHLORPHENIRAMINE JAMA 231:734 1975 68 YRS M NO YES 1 2 NA NO

CHLORPHENIRAMINE JAMA 231:735 1975 53 YRS M NR YES NR 3 NA NO

CHLORPROMAZINE AM J PSYCHIATRY 116:845-846 1960 NR NR NR YES NR 4 NA NO

CHLORPROMAZINE CURR THER RES CLIN EXP 18:199 1975 28 YRS F NR YES NR 3 NA NO

CHLORPROMAZINE J CLIN PSYCHIATRY 39:779-781 1978 29 YRS M NR YES NR 4 NA NO

CHLORPROMAZINE DICP 17:437 1983 NR NR NR NO NR 5 1 NO

CHLORPROMAZINE CAN J PSYCHIATRY 32:149-150 1987 59 YRS F NO YES 0 1 NA NO

CHLORPROPAMIDE BMJ 2:1403 1959 40 YRS M NO YES 3 2 NA NO

CHLORPROPAMIDE NEJM 260:711-712 1959 47 YRS M NO YES 1 2 NA NO

CHLORPROPAMIDE DIABETES 12:457 1963 53 YRS F NO YES 0 2 NA NO

CHLORPROPAMIDE MED J AUST 2:988 1964 50 YRS F NO YES 2 2 NA NO

CHLORPROPAMIDE POSTGRAD MED J 53:87 1977 64 YRS F NO NO 1 2 NA NO

CHROMIUM PICOLINATE ANN PHARMACOTHER 32: 428-431 1998 33 YRS F YES NO 0 3 NA NO

CIMETIDINE LANCET 1:987 1978 41 YRS M NR YES NR 3 NA NO

CIMETIDINE NEJM 300:864 1979 77 YRS F NO YES 0 2 NA NO

CIMETIDINE ANN INTERN MED 91:795 1979 53 YRS F NR YES NR 3 NA NO

CIMETIDINE LANCET 2:159 1979 75 YRS M NR YES NR 3 NA NO

CIMETIDINE LANCET 2:159 1979 57 YRS M NR YES NR 3 NA NO

CIMETIDINE BMJ 280:294 1980 43 YRS M NO YES 1 2 NA NO

CIMETIDINE BMJ 280:1453 1980 72 YRS M NR YES NR 3 NA NO

Page 9: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

CIMETIDINE N Z MED J 91:232 1980 46 YRS F NR YES NR 4 NA NO

CIMETIDINE DIG DIS SCI 25:960-963 1980 67 YRS M NR YES NR 5 2 NO

CIMETIDINE WEST J MED 132:257-258 1980 52 YRS M NR YES NR 5 1 NO

CIMETIDINE J NATL MED ASSOC 73:92 1981 64 YRS F NR YES NR 3 NA NO

CIMETIDINE WEST J MED 135:330-336 1981 57 YRS F NR YES NR 4 NA NO

CIMETIDINE SOUTH MED J 75:232-234 1982 62 YRS M NO YES 2 1 NA NO

CIMETIDINE SOUTH MED J 75:1283-1284 1982 45 YRS F NO YES 0 2 NA NO

CIMETIDINE DICP 17:126-128 1983 65 YRS F NR YES NR 3 NA NO

CIMETIDINE SURG NEUROL 23:169-172 1985 67 YRS M NR YES NR 3 NA NO

CIMETIDINE NEUROSURGERY 20:963-965 1987 68 YRS M NR NO NR 3 NA NO

CIMETIDINE NEUROSURGERY 20:963-965 1987 22 YRS M NR NO NR 4 NA NO

CIMETIDINE NEUROSURGERY 20:963-965 1987 58 YRS M NR NO NR 5 1 NO

CIMETIDINE NEUROSURGERY 20:963-965 1987 65 YRS M NR NO NR 5 1 NO

CIMETIDINE ARCH DIS CHILD 63:998 1988 6 DAYS M NO YES 2 3 NA NO

CIMETIDINE ARCH DIS CHILD 63:88-89 1988 NEONATE F NR NO NR 5 1,2,7 NO

CIMETIDINE DICP 23:177-178 1989 57 YRS F NO YES 1 2 NA NO

CIMETIDINE DICP 24:1007-1008 1990 76 YRS M NO YES 0 2 NA NO

CIMETIDINE J INTERN MED 230:87-88 1991 66 YRS M NR YES NR 3 NA NO

CINOBUFACINI (BUFO BUFO GARGARIZANS) AND JIEDU

J INTEGR MED 11: 90-100 2013 NR NR NR NR NR 4 NA NO

CIPROFLOXACIN J INFECT 27:213-215 1993 80 YRS F NR NO NR 4 NA NO

CIPROFLOXACIN CLIN LAB HAEMATOL 19:223-224 1997 42 YRS M NR NO NR 5 7 NO

CIPROFLOXACIN POSTGRAD MED J 75:571-3 1999 24 YRS M NO YES 0 3 NA NO

CIPROFLOXACIN POSTGRAD MED J 75:571-3 1999 25 YRS M YES YES 3 5 1 NO

CIPROFLOXACIN PHARMACOTHERAPY 25:1030-1034 2005 72 YRS F NO YES 0 2 NA NO

CIPROFLOXACIN PLATELETS 19:384-7 2008 30 YRS M NR NR NR 5 7 YES

CIPROFLOXACIN INTERN MED J 39:619 2009 76 YRS M NO YES 0 1 NA NO

CIPROFLOXACIN AM J THER 17:E167-8 2010 50 YRS F NO YES NR 2 NA YES

CIPROFLOXACIN KAOHSIUNG J MED SCI 31:110-1 2015 61 YRS F NR YES NR 3 NA YES

CIPROFLOXACIN J CLIN PHARM THER 43:134-6 2018 77 YRS F NO YES NR 1 NA YES

CITALOPRAM PSYCHOSOMATICS 2009 32 YRS F NO YES 2 2 NA NO

CITRUS FLAVONOIDS THERAPIE 70:555-6 2015 62 YRS M NO YES 2 1 NA YES

CLARITHROMYCIN CLIN INFECT DIS 15:563 1992 30 YRS M NR YES NR 3 NA NO

Page 10: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

CLARITHROMYCIN CLIN INFECT DIS 19:1170 1994 74 YRS M NO NO 1 2 NA NO

CLARITHROMYCIN CLIN INFECT DIS 29:1350 1999 77 YRS M NR NO NR 5 7 NO

CLARITHROMYCIN/ OMEPRAZOLE/AMOXYCILLIN

DIG LIVER DIS 34:665-667 2002 56 YRS F NO YES 2 4 NA NO

CLIDINIUM/ CHLORDIAZEPOXIDE

BMJ 1:268 1977 32 YRS F NO YES 1 2 NA NO

CLIDINIUM/ CHLORDIAZEPOXIDE

ARCH INTERN MED 161:1778 2001 68 YRS M NO YES 2 2 NA NO

CLONAZEPAM BMJ 4:462 1975 52 YRS F NR YES NR 3 NA NO

CLOPIDOGREL J INVASIVE CARDIOL 12:532 2000 66 YRS M NR YES 0 2 NA NO

CLOPIDOGREL INT J CLIN PHARMACOL THER 51: 228-231 2013 73 YRS F NR NR NR 4 NA NO

CLOZAPINE SOUTH MED J 86:1170-1072 1993 45 YRS M NR NO NR 4 NA NO

CLOZAPINE PHARMACOPSYCHIATRY 29:227-228 1996 19 YRS M NR YES NR 4 NA NO

CLOZAPINE J NEURAL TRANSM 104:1305-1311 1997 72 YRS M NR NO NR 3 NA NO

CLOZAPINE NORD J PSYCHIATRY 55: 449-450 2001 24 YRS M NR NR NR 4 NA NO

COCHINCINE/NIVOLUMAB ACTA ONCOL 54:1235-7 2015 70 YRS M NR NR NR 5 2 YES

COLCHICINE VET HUM TOXICOL 37:366-7 1995 3 YRS F NR NR NR 5 6 NO

CRANBERRY JUICE LANCET 358: 2126 2001 68 YRS M YES NO 2 1 NA NO

CUPRESSUS FUNEBRIS (MOURNING CYPRESS)

AM J KIDNEY DIS 48(5): E81-E85 2006 62 YRS F YES NO 1 3 NA NO

CYCLOPHOSPHAMIDE BLUT 46:165-169 1983 55 YRS F NR YES NR 5 3 NO

CYCLOSPORIN AUST N Z J MED 20:749 1990 61 YRS F NR YES NR 3 NA NO

CYCLOSPORIN DICP 24:1007-1008 1990 70 YRS M NR YES NR 4 NA NO

CYCLOSPORIN ACTA UNIV CAROLINAE MED 40: 105-108 1994 NR NR NR NR NR 5 1 NO

DABIGATRAN BMC NEUROL 17:1-4 2017 73 YRS M NO YES 2 2 NA YES

DABIGATRAN BMC NEUROL 17:1-4 2017 75 YRS F NO YES 0 2 NA YES

DACTINOMYCIN/ACTINOMYCIN J PEDIATR 107:611-614 1985 NR NR NR NO NR 5 3,7 NO

DACTINOMYCIN/ACTINOMYCIN J PEDIATR 107:611-614 1985 NR NR NR NO NR 5 3 NO

DACTINOMYCIN/ACTINOMYCIN J PEDIATR 108:1039-1040 1986 4 YRS M NR NO NR 5 3 NO

DACTINOMYCIN/ACTINOMYCIN CLIN PEDIATR (PHILA) 29:196-197 1990 CHILD NR NR NO NR 5 1,3 NO

DALTEPARIN BMJ CASE REP 2016218919 2017 25 YRS F NR NR NR 5 2 YES

DANAZOL NEJM 315:585 1986 NR F NO NO 1 1 NA NO

DANAZOL NEJM 315:585 1986 NR F NO NO 2 2 NA NO

Page 11: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

DANAZOL NEJM 315:585 1986 NR F NO NO 2 2 NA NO

DANAZOL NEJM 315:585 1986 NR F NO NO 1 2 NA NO

DANAZOL BR J HAEMATOL 65:383-384 1987 73 YRS M NO YES 2 1 NA NO

DANAZOL EUR J HAEMATOL 45:109-110 1990 NR NR NR NO NR 5 1 NO

DANAZOL BR J HAEMATOL 90:969-973 1995 NR F NO YES 2 2 NA NO

DANAZOL TOHOKU J EXP MED 182:249-252 1997 34 YRS F NO YES 1 1 NA NO

DEFEROXAMINE AM J KIDNEY DIS 6:254 1985 57 YRS M NO NO 0 1 NA NO

DESIPRAMINE BLOOD 32:524-535 1968 60 YRS F NO NO 1 2 NA NO

DESIPRAMINE BLOOD 32:524-535 1968 NR NR NR NO NR 3 NA NO

DESMOPRESSIN AM J HEMATOL 43:5-9 1993 NR M NR NR NR 5 2,4,7 NO

DESMOPRESSIN AM J HEMATOL 43:5-9 1993 39 YRS M NR NR NR 5 4 NO

DESMOPRESSIN ANESTHESIOLOGY 88:1115-1117 1998 48 YRS F YES YES NR 5 4 NO

DEXAMETHASONE BLOOD 131:1486-9 2018 74 YRS F NR NR NR 1 NA YES

DEXAMETHASONE BLOOD 131:1486-9 2018 53 YRS M NR NR NR 1 NA YES

DIATRIZOATE MEGLUMINE CATHET CARDIOVASC DIAGN 8:495-499 1982 29 YRS M NR YES NR 3 NA NO

DIATRIZOATE MEGLUMINE CAN MED ASSOC J 133:123 1985 60 YRS M NO YES 2 1 NA NO

DIATRIZOATE MEGLUMINE CAN MED ASSOC J 133:123 1985 57 YRS F NO YES 2 2 NA NO

DIATRIZOATE MEGLUMINE JAP J NEPHROL 33:61-64 1991 52 YRS M NO YES 0 2 NA NO

DIATRIZOATE MEGLUMINE/ DIATRIZOATE SODIUM

AJR AM J ROENTGENOL 146:1298-1299 1986 79 YRS M NO YES 1 1 NA NO

DIATRIZOATE MEGLUMINE/ DIATRIZOATE SODIUM

AJR AM J ROENTGENOL 152:947-949 1989 66 YRS F NO YES 0 1 NA NO

DIAZEPAM AM J HEMATOL 2:65-72 1977 45 YRS F NR NO NR 3 NA NO

DIAZEPAM ACTA HAEMATOL 70:386-388 1983 59 YRS F NO NO 1 1 NA NO

DIAZEPAM ACTA HAEMATOL 70:386-388 1983 31 YRS F NR NO NR 4 NA NO

DIAZOXIDE LANCET 1:53-54 1967 41 YRS F NO NO 0 1 NA NO

DIAZOXIDE PEDIATRICS 40:90-92 1967 15 YRS M NR NO NR 2 NA NO

DICLOFENAC ITAL J GASTROENTEROL HEPATOL 16:54 1984 69 YRS M NO YES 1 2 NA NO

DICLOFENAC SCAND J HAEMATOL 36:118-120 1986 71 YRS F NR YES NR 3 NA NO

DICLOFENAC J RHEUMATOL 17:1403-1404 1990 53 YRS F NO NO 1 1 NA NO

DICLOFENAC J INTERN MED 230:543-547 1991 59 YRS F NR YES NR 3 NA NO

DICLOFENAC ANN PHARMACOTHER 29:713-715 1995 63 YRS F NO YES 2 1 NA NO

DICLOFENAC AM J HEALTH-SYST PHARM 52:420-421 1995 55 YRS M NO YES 2 2 NA NO

Page 12: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

DICLOFENAC AM J GASTROENTEROL 95:2988 2000 69 YRS M NR NO NR 5 7 NO

DICLOFENAC TRANSFUSION 43:345-349 2003 37 YRS F NO YES 2 2 NA NO

DICLOFENAC TRANSFUSION 43:345-349 2003 74 YRS F NR NO NR 3 NA NO

DIDANOSINE ANN PHARMACOTHER 27:23-25 1983 42 YRS M NR NO NR 3 NA NO

DIETHYLSTILBESTROL ANN INTERN MED 52:907-909 1960 88 YRS M NO YES 0 1 NA NO

DIETHYLSTILBESTROL PROSTATE 1:105-109 1980 NR NR NR NO NR 5 1 NO

DIFLOUROMETHYLORNITHINE (EFLORNITHINE)

DICP 21:627-630 1987 32 YRS M NO YES 0 1 NA NO

DIFLOUROMETHYLORNITHINE (EFLORNITHINE)

CANCER RES 49:5761-5765 1989 NR NR NR NO NR 5 1 NO

DIFLUNISAL ARTHRITIS RHEUM 31:148-149 1988 37 YRS M NO YES 0 2 NA NO

DIGITOXIN JPN CIRC J 64:309 2000 46 YRS F NO YES 0 2 NA NO

DIGOXIN JAMA 148:282-283 1952 70 YRS F NO YES 2 1 NA NO

DIGOXIN J CLIN INVEST 43:1236-1237 1964 NR NR NR NO NR 5 1 NO

DIGOXIN AM J MED 41:605-614 1966 55 YRS M NO YES 2 1 NA NO

DIGOXIN INT ARCH ALLERGY APPL IMMUNOL 43:1-8 1972 76 YRS F NR YES NR 3 NA NO

DIGOXIN EUR J CLIN PHARMACOL 19:205-207 1981 60 YRS M NO YES 0 1 NA NO

DIGOXIN EUR J CLIN INVEST 13:159-163 1983 77 YRS M NR YES NR 3 NA NO

DILTIAZAM SURG NEUROL 25:82 1986 NR NR NR NO NR 5 1,2 NO

DILTIAZAM MT SINAI J MED 54:500-504 1987 68 YRS M NR YES NR 3 NA NO

DILTIAZAM ANN INTERN MED 110:327 1989 61 YRS M NO YES 0 2 NA NO

DILTIAZAM MT SINAI J MED 56:77 1989 NR NR NR NO NR 5 1 NO

DILTIAZAM PHARMACOTHERAPY 17:1345-1348 1997 74 YRS M NR NO NR 3 NA NO

DIPYRIDAMOLE CLIN APPL THROMB HEMOST 17:103-5 2011 23 YRS F NO YES NR 3 NA NO

DOLUTEGRAVIR INTERN MED 56:2229-32 2017 56 YRS M NO YES 0 3 NA YES

DORZOLAMIDE J GLAUCOMA 10:133-135 2001 83 YRS M NO NO 0 4 NA NO

DORZOLAMIDE WEST INDIAN MED J 59:102-5 2010 63 YRS M NR NR NR 4 NA NO

DOXEPIN JAMA 220:418 1972 73 YRS F NR YES NR 4 NA NO

DOXEPIN J CLIN PSYCHIATRY 50:99-100 1989 46 YRS M NO YES 0 2 NA NO

ECHINACEA PALLIDA AM J HEMATOL 81: 224 2006 32 YRS M YES NO 1 3 NA NO

EDTA J AM BOARD FAM PRACT 9:212-214 1996 NR NR NR NO NR 5 1 NO

EFALIZUMAB (RAPTIVA) ARCH DERMATOL 143:1077-8 2007 CHILD M NO NO 2 5 1 NO

EFALIZUMAB (RAPTIVA) CLIN EXP DERMATOL 34:E914-6 2009 52 YRS M NO YES 0 3 NA NO

Page 13: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

ELTROMBOPAG PRESCRIRE INT 24:208-9 2015 NR NR NR NR NR 5 1 YES

ENALAPRIL BMJ 298:189-190 1989 76 YRS F NR YES NR 4 NA NO

ENOXAPARIN CARDIOVASC J AFR 27:E5-8 2016 75 YRS F NO YES NR 5 7 YES

ENTECAVIR MEDICINE (BALTIMORE) 95:E3103 2016 65 YRS F NR YES NR 4 NA YES

ENZALUTAMIDE BMJ CASE REP 2015212567 2015 69 YRS M NO YES NR 4 NA YES

EPTIFIBATIDE AM J CARDIOL 88:428-431 2001 62 YRS M NR NO NR 3 NA NO

EPTIFIBATIDE AM J CARDIOL 88:428-431 2001 68 YRS M NR NO NR 3 NA NO

EPTIFIBATIDE AM J CARDIOL 88:428-431 2001 74 YRS F NR NO NR 3 NA NO

EPTIFIBATIDE AM J CARDIOL 88:428-431 2001 86 YRS F NR NO NR 3 NA NO

EPTIFIBATIDE CATHETER CARDIOVASC INTERV 54:63-67 2001 44 YRS M NO YES 0 3 NA NO

EPTIFIBATIDE ANN PHARMACOTHER 36:628-630 2002 61YRS M NR NO NR 3 NA NO

EPTIFIBATIDE BLOOD 100:2071-6 2002 65 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE BLOOD 100:2071-6 2002 73 YRS M NO YES 3 3 NA NO

EPTIFIBATIDE BLOOD 100:2071-6 2002 79 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE BLOOD 100:2071-6 2002 59 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE BLOOD 100:2071-6 2002 81 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE CAN J CARDIOL 19:797-801 2003 67 YRS F NO YES 0 2 NA NO

EPTIFIBATIDE J THROMB HAEMOST 1:2685-2687 2003 55 YRS M NO YES 0 2 NA NO

EPTIFIBATIDE J THROMB HAEMOST 1:392-394 2003 55 YRS M NO YES 0 2 NA NO

EPTIFIBATIDE PHARMACOTHERAPY 23:374-379 2003 79 YRS M NO YES 1 2 NA NO

EPTIFIBATIDE CAN J CARDIOL 19:797-801 2003 47 YRS M NO YES 0 3 NA NO

EPTIFIBATIDE CAN J CARDIOL 19:797-801 2003 45 YRS M NO YES 0 3 NA NO

EPTIFIBATIDE CATHETER CARDIOVASC INTERV 58:73-75 2003 78 YRS M NO YES 1 3 NA NO

EPTIFIBATIDE CATHETER CARDIOVASC INTERV 58:76-79 2003 61 YRS F NO YES 1 3 NA NO

EPTIFIBATIDE PHARMACOTHERAPY 23:374-379 2003 80 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE ANN PHARMACOTHER 39:368-372 2005 40 YRS F NO YES 1 3 NA NO

EPTIFIBATIDE ANN PHARMACOTHER 39:368-372 2005 67 YRS F YES YES NR 3 NA NO

EPTIFIBATIDE ANN PHARMACOTHER 39:368-372 2005 72 YRS M NO YES 2 3 NA NO

EPTIFIBATIDE AM J HEMATOL 81:984-8 2006 84 YRS M NO YES 0 2 NA NO

EPTIFIBATIDE J THROMB THROMBOLYSIS 22:151-4 2006 75 YRS M NO YES 0 2 NA NO

EPTIFIBATIDE J INTERV CARDIOL 19:99-103 2006 86 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE J THROMB THROMBOLYSIS 25:204-6 2008 34 YRS M NO YES 0 2 NA NO

EPTIFIBATIDE BLOOD 114:1250-3 2009 67 YRS M NO YES 3 2 NA NO

Page 14: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

EPTIFIBATIDE PHARMACOTHERAPY 29:867-74 2009 50 YRS F NO YES 3 2 NA NO

EPTIFIBATIDE SOUTH MED J 103:596-7 2010 84 YRS F NO YES 3 3 NA NO

EPTIFIBATIDE TEX HEART INST J 38:174-8 2011 57 YRS M NO NO 0 2 NA NO

EPTIFIBATIDE GYNECOL ONCOL CASE REP 2:75-7 2012 65 YRS F NR NR NR 3 NA NO

EPTIFIBATIDE TEX HEART INST J 39:86-91 2012 73 YRS M NR NR NR 5 7 NO

EPTIFIBATIDE AM J THER 23:E298-9 2016 71 YRS M NO YES 1 2 NA YES

ETANERCEPT RHEUMATOLOGY 45:1313-4 2006 44 YRS F NO NO 0 3 NA NO

ETANERCEPT ACTA DERM VENEREOL 88:281-2 2008 61 YRS M NO NO 0 4 NA NO

ETANERCEPT J AM ACAD DERMATOL 60:781-5 2009 53 YRS M NO NO 0 1 NA NO

ETANERCEPT J AM ACAD DERMATOL 60:781-5 2009 67 YRS F NO NO NR 4 NA NO

ETANERCEPT J DERMATOLOG TREAT 21:117-8 2010 55 YRS M NR NR NR 4 NA NO

ETANERCEPT REV BRAS REUMATOL 52:107-112 2011 54 YRS F NO NO 2 2 NA NO

ETANERCEPT REV BRAS REUMATOL 52:107-112 2011 43 YRS M NO NR NR 4 NA NO

ETHAMBUTOL CHEST 81:765-766 1982 71 YRS F NO YES 3 2 NA NO

ETHAMBUTOL TUBERCLE 70:211 1989 40 YRS M NO YES 1 1 NA NO

ETHAMBUTOL INT J DERMATOL 54:819-22 2015 32 YRS M NO NR NR 4 NA YES

ETHCHLORVYNOL ANN INTERN MED 77:73-76 1972 53 YRS F NR NO NR 3 NA NO

ETRETINATE ACTA HAEMATOL 79:112-113 1988 37 YRS F NO YES 3 2 NA NO

ETRETINATE BR J DERMATOL 124:395 1991 54 YRS M NR NO NR 3 NA NO

ETRETINATE J DERMATOL 32:917-920 2005 79 YRS M NO YES 2 2 NA NO

EXCITALOPRAM AUST N Z J PSYCHIATRY 51:1055-6 2017 31 YRS M NO NR 0 5 2 YES

EZETIMIBE ANN PHARMACOTHER 42:430-3 2008 72 YRS M NO YES 3 2 NA NO

FAMOTIDINE DICP 23:507-508 1989 37 YRS M NR YES NR 3 NA NO

FAMOTIDINE DICP 25:678 1991 79 YRS M NR YES NR 3 NA NO

FAMOTIDINE ANN PHARMACOTHER 26:262 1992 23 YRS M NR NO NR 3 NA NO

FAMOTIDINE ANN PHARMACOTHER 28:406-407 1994 62 YRS M NO YES 0 2 NA NO

FELBAMATE NEUROLOGY 44:980-981 1994 26 YRS M NO YES 1 2 NA NO

FENOPROFEN NEJM 298:629-630 1978 86 YRS M NR YES NR 3 NA NO

FENOPROFEN ANN INTERN MED 92:262 1980 81 YRS F NO YES 0 2 NA NO

FEPRAZONE BMJ 284:17 1982 21 YRS M NO YES 2 2 NA NO

FERROUS GLUCONATE AM J MED SCI 295:35-39 1988 17 YRS F NR NO NR 4 NA NO

FERROUS SULFATE AM J MED SCI 295:35-39 1988 17 YRS F NR NO NR 5 2 NO

Page 15: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

FILGRASTIM (GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF))

RHEUMATOLOGY 41:471-473 2002 58 YRS F NO YES 0 5 5 NO

FILGRASTIM (GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF))

TURK J HEMATOL 23:59-62 2006 24 MOS M NR NR NR 5 5 NO

FILGRASTIM (GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF))

BONE MARROW TRANSPLANT 43:263-4 2009 51 YRS M NO YES 0 5 5 NO

FILGRASTIM (GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF))

PEDIATR BLOOD CANCER 54:1014-6 2010 5 DAYS F NO YES 3 5 5 NO

FINASTERIDE BJU INTERNATIONAL 90:348-349 2002 66 YRS M NO YES 2 2 NA NO

FLUCLOXACILLIN TRANSFUSION 56:67-72 2016 68 YRS M NR NR 2 1 NA YES

FLUCONAZOLE ANN INTERN MED 113:899 1990 37 YRS M NO YES 1 2 NA NO

FLUCONAZOLE J AM ACAD DERMATOL 32:525-526 1995 47 YRS F NO NO 0 2 NA NO

FLUCONAZOLE J AM ACAD DERMATOL 32:525-526 1995 71 YRS F NR NO NR 3 NA NO

FLUCONAZOLE PHARMACOTHERAPY 22:697-700 2002 74 YRS M NR NO NR 5 1 NO

FLUCONAZOLE INT J CLIN PHARM 36: 268-70 2014 66 YRS F NR NR NR 3 NA NO

FLUCYTOSINE DICP 23:672-674 1989 41 YRS M NR YES NR 3 NA NO

FLUDARABINE CLIN LAB HAEMATOL 22:175-178 2000 72 YRS M NR NO NR 5 3 NO

FLUDARABINE CLIN LAB HAEMATOL 22:175-178 2000 44 YRS M NR NO NR 5 3 NO

FLUDARABINE CLIN ONC 13:273-275 2001 46 YRS M NR NO NR 5 3 NO

FLUDARABINE HAEMATOLOGICA 88:ELT02 2003 79 YRS F NR NO NR 5 3 NO

FLUDARABINE J PAK MED ASSOC 53:496-497 2003 50 YRS F NR NO NR 5 3 NO

FLUOXETINE J CLIN PSYCHOPHARMACOL 35:354-5 2015 44 YRS M NR NR NR 2 NA YES

FLUOXETINE J CLIN PSYCHOPHARMACOL 35:354-5 2015 32 YRS M NO NR 2 2 NA YES

FLUOXETINE J CLIN PSYCHOPHARMACOL 35:354-5 2015 35 YRS F NR NR 2 4 NA YES

FLUPHENAZINE PHARMACOL THERAPEUTICS 4:227-229 1984 30 YRS M NR YES NR 4 NA NO

FORMESTANE HAEMATOLOGICA 83:953-954 1998 55 YRS F NO NO 0 2 NA NO

FOTEMUSTINE MELANOMA RES 16:543-4 2006 66 YRS M NO NO NR 5 3 NO

FUROSEMIDE LANCET 1:1210 1981 87 YRS M NR YES NR 4 NA NO

FUSIDIC ACID POSTGRAD MED J 67:591-592 1991 49 YRS F NR NO NR 3 NA NO

FUSIDIC ACID BR J HAEMATOL 93:427-431 1996 48 YRS NR NR YES NR 3 NA NO

Page 16: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

GABAPENTIN IDEGGYOGY SZ 68:270-2 2015 33 YRS M NO YES NR 2 NA YES

GALSULFASE HUM EXP TOXICOL 30:768-71 2011 5 YRS M NO NR 0 4 NA NO

GANCICLOVIR AM J OPHTHALMOL 107:560-561 1989 38 YRS M NR YES NR 4 NA NO

GARBHAPAL RAS (AYURVEDIC MEDICINE)

INDIAN J GASTROENTEROL 22: 111 2003 NR F NR NR NR 5 1 NO

GEMCITABINE J NATL CANCER INST 89:1164 1997 62 YRS M NO YES NR 5 3,7 NO

GEMCITABINE ACTA ONCOL 46:545-456 2007 61 YRS NR NR NR NR 5 2,3 NO

GEMCITABINE ACTA ONCOL 46:545-456 2007 59 YRS NR NR NR NR 5 3 NO

GEMCITABINE ACTA ONCOL 46:545-456 2007 65 YRS NR NR NR NR 5 3 NO

GENTAMICIN N Y STATE J MED 80:1134-1135 1980 69 YRS F NR YES NR 4 NA NO

GLUCAGON PEDIATRICS 107:595-7 2001 NEONATE F NO YES 0 2 NA NO

GLYBURIDE KLINISCHE WOCHENSCHRIFT 66:223-224 1988 64 YRS F NO YES 2 2 NA NO

GLYBURIDE KLINISCHE WOCHENSCHRIFT 66:223-224 1988 62 YRS F NO YES 1 2 NA NO

GLYBURIDE HAREFUAH 122:430 1992 NR NR NR NO NR 5 1 NO

GOLD LANCET 2:8-11 1935 45 YRS F NR NO NR 4 NA NO

GOLD LANCET 2:8-11 1935 63 YRS F NR YES NR 4 NA NO

GOLD LANCET 2:838 1937 NR NR NR NO NR 5 1 NO

GOLD JAMA 133:754-755 1947 34 YRS M NR YES NR 3 NA NO

GOLD BLOOD 3:1105-1111 1948 44 YRS F NO YES 3 2 NA NO

GOLD BLOOD 3:1105-1111 1948 50 YRS M NO YES 2 2 NA NO

GOLD BLOOD 3:1105-1111 1948 33 YRS F NR NO NR 3 NA NO

GOLD BLOOD 3:1105-1111 1948 44 YRS F NR YES NR 4 NA NO

GOLD ANN MED INTERN FENN 38:33-37 1949 53 YRS M NR NO NR 4 NA NO

GOLD ACTA MED SCAND 141:27-35 1951 46 YRS F NR YES NR 4 NA NO

GOLD BMJ 1:899-902 1954 44 YRS F NO YES 3 2 NA NO

GOLD BMJ 1:899-902 1954 49 YRS M NR YES NR 4 NA NO

GOLD CAN MED ASSOC J 79:31-33 1958 62 YRS F NR YES NR 4 NA NO

GOLD JAMA 195:782-784 1966 57 YRS F NR YES NR 4 NA NO

GOLD SCAND J HAEMATOL 5:271-277 1968 63 YRS F NO NO 1 2 NA NO

GOLD BMJ 2:748-749 1972 56 YRS F NO YES 1 2 NA NO

GOLD AM J HOSP PHARM 30:340-342 1973 51 YRS F NR YES NR 4 NA NO

GOLD ANN RHEUM DIS 32:277-278 1973 NR NR NR NO NR 5 1 NO

GOLD CONN MED 38:592-594 1974 52 YRS F NO YES 2 2 NA NO

Page 17: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

GOLD ARCH INTERN MED 134:1012-1015 1974 60 YRS F NR NO NR 3 NA NO

GOLD ARCH INTERN MED 134:1012-1015 1974 65 YRS M NR NO NR 3 NA NO

GOLD ARCH INTERN MED 134:1012-1015 1974 54 YRS F NR NO NR 3 NA NO

GOLD ARCH INTERN MED 134:1012-1015 1974 55 YRS F NR NO NR 3 NA NO

GOLD ARCH INTERN MED 134:1012-1015 1974 62 YRS F NR NO NR 3 NA NO

GOLD ARCH INTERN MED 134:1012-1015 1974 43 YRS F NR NO NR 3 NA NO

GOLD CONN MED 38:592-594 1974 57 YRS F NR YES NR 5 7 NO

GOLD ARCH INTERN MED 135:1622-1623 1975 69 YRS F NO NO 1 2 NA NO

GOLD AM J MED 59:274-280 1975 46 YRS F NR YES NR 4 NA NO

GOLD ARCH INTERN MED 135:1622-1623 1975 52 YRS F NR NO NR 4 NA NO

GOLD ARCH INTERN MED 135:1622-1623 1975 65 YRS F NR NO NR 4 NA NO

GOLD ARTHRITIS RHEUM 19:936-938 1976 67 YRS M NR YES NR 4 NA NO

GOLD BMJ 1:1266-1268 1976 NR NR NR NO NR 5 1 NO

GOLD ARTHRITIS RHEUM 20:1288-1289 1977 39 YRS F NR YES NR 3 NA NO

GOLD JAMA 239:50-51 1978 76 YRS M NR YES NR 4 NA NO

GOLD J RHEUMATOL 5:165-172 1978 NR NR NR NO NR 5 1 NO

GOLD SOUTH MED J 72:1490 1979 51 YRS M NR YES NR 4 NA NO

GOLD J RHEUMATOL 6:359-361 1979 33 YRS F NR NO NR 5 1 NO

GOLD J RHEUMATOL 7:430 1980 39 YRS M NR NO NR 4 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

Page 18: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR M NR NO NR 3 NA NO

GOLD ANN INTERN MED 95:178-181 1981 NR F NR NO NR 3 NA NO

GOLD SCOT MED J 27:247-249 1982 55 YRS F NO NO 3 2 NA NO

GOLD SCOT MED J 27:247-249 1982 59 YRS F NO NO 2 2 NA NO

GOLD CLIN RHEUMATOL 2:183-188 1983 44 YRS F NR YES NR 4 NA NO

GOLD J RHEUMATOL 11:355-357 1984 51 YRS F NR NO NR 3 NA NO

GOLD J RHEUMATOL 11:355-357 1984 50 YRS F NR NO NR 3 NA NO

GOLD J RHEUMATOL 11:355-357 1984 49 YRS F NR NO NR 3 NA NO

GOLD IR MED J 78:167-169 1985 59 YRS F NR NO NR 4 NA NO

GOLD IR MED J 78:167-169 1985 54 YRS F NR NO NR 4 NA NO

GOLD IR MED J 78:167-169 1985 53 YRS F NR NO NR 4 NA NO

GOLD IR MED J 78:167-169 1985 62 YRS F NR NO NR 4 NA NO

GOLD ANN RHEUM DIS 44:589-591 1985 NR NR NR NO NR 5 1 NO

GOLD ARTHRITIS RHEUM 29:426-430 1986 63 YRS F NR YES NR 3 NA NO

GOLD J RHEUMATOL 13:225-227 1986 23 YRS F NR NO NR 3 NA NO

GOLD J RHEUMATOL 13:225-227 1986 47 YRS M NR NO NR 3 NA NO

GOLD J RHEUMATOL 13:225-227 1986 54 YRS F NR NO NR 3 NA NO

GOLD BR J HAEMATOL 63:509-516 1986 NR NR NR NO NR 5 1 NO

GOLD SEMIN ARTHRITIS RHEUM 16:287-293 1987 NR NR NR NO NR 5 1 NO

GOLD ARTHRITIS RHEUM 31:299-300 1988 69 YRS F NR YES NR 3 NA NO

GOLD J RHEUMATOL 15:1450 1988 48 YRS F NR NO NR 4 NA NO

GOLD AM J HEMATOL 30:236-239 1989 60 YRS F NO YES 1 2 NA NO

GOLD ANN RHEUM DIS 49:798-800 1990 56 YRS F NO NO 0 2 NA NO

GOLD BR J RHEUMATOL 30:75-76 1991 59 YRS M NR NO NR 3 NA NO

GOLD NETH J MED 61:223-225 2003 47 YRS F NO NO NR 3 NA NO

GOLD NETH J MED 61:223-225 2003 51 YRS F NO NO NR 3 NA NO

Page 19: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

HALOPERIDOL J CLIN PSYCHIATRY 39:779-781 1978 29 YRS M NR YES NR 4 NA NO

HALOPERIDOL CAN J PSYCHIATRY 32:149-150 1987 59 YRS F NO YES 0 1 NA NO

HALOPERIDOL AM J PSYCHIATRY 148:1266 1991 24 YRS F NR NO NR 4 NA NO

HEPATITIS B VACCINE JAMA 107:120 1936 5 MOS NR NR NO NR 5 1 NO

HEPATITIS B VACCINE JAMA 107:120 1936 4 YRS F NO NO NR 5 1 NO

HEPATITIS B VACCINE JAMA 107:120 1936 5 YRS F YES YES 3 5 2 NO

HEPATITIS B VACCINE LANCET 344:1293 1994 21 YRS F NR NO NR 4 NA NO

HEPATITIS B VACCINE LANCET 344:1293 1994 15 YRS F NO YES 0 5 1 NO

HEPATITIS B VACCINE ARCH DIS CHILD 78:273-274 1998 4 MOS F NO YES 0 2 NA NO

HEPATITIS B VACCINE ARCH DIS CHILD 78:273-274 1998 3 MOS M NO YES 0 3 NA NO

HEPATITIS B VACCINE ARCH DIS CHILD 78:273-274 1998 3 MOS M NO YES 0 3 NA NO

HEPATITIS B VACCINE EUR J PEDIATR 158:S209-210 1999 11 YRS M NR NO NR 5 1 NO

HEPATITIS B VACCINE HAEMATOLOGICA 86:E09 2001 18 YRS F NO YES 0 2 NA NO

HEPATITIS B VACCINE PEDIATR INFECT DIS J 23:183-184 2004 45 DAYS F NO YES 2 4 NA NO

HEPATITIS B VACCINE VACCINE 26:6495-6 2008 46 DAYS F NR NR 2 2 NA NO

HERBAL "COLON CLEANSING" PREPARATION

J EMERG MED 36: 191 2009 51 YRS F NR NR NR 4 NA NO

HUMAN PAPILLOMAVIRUS VACCINE

VACCINE 27:3690 2009 16 YRS F NO YES 2 2 NA NO

HYDRALAZINE NEJM 303:1235 1980 33 WKS F NR NR NR 5 8 NO

HYDRALAZINE NEJM 303:1235 1980 NEONATE F NO YES NR 5 8 NO

HYDRALAZINE NEJM 303:1235 1980 NEONATE F NO YES NR 5 8 NO

HYDROCHLOROTHIAZIDE JAMA 173:663-665 1960 61 YRS F NO NO 1 2 NA NO

HYDROCHLOROTHIAZIDE JAMA 172:556-259 1960 55 YRS F NR NO NR 4 NA NO

HYDROCHLOROTHIAZIDE ARCH INTERN MED 112:78 1963 44 YRS F NO NO 1 2 NA NO

HYDROCHLOROTHIAZIDE JAMA 215:480 1971 73 YRS M NO YES 2 2 NA NO

HYDROCHLOROTHIAZIDE J PEDIATR 77:1097-1098 1973 NR NR NR NO NR 5 1 NO

HYDROCHLOROTHIAZIDE WEST J MED 138:101-102 1983 50 YRS F NO YES 1 2 NA NO

HYDROCHLOROTHIAZIDE DICP 20:60-61 1986 65 YRS M NO YES 2 2 NA NO

HYDROXYCHLOROQUINE ANN RHEUM DIS 49:798-800 1990 56 YRS F NR NO NR 3 NA NO

HYDROXYUREA CUTIS 20:95 1977 47 YRS M NR NO NR 5 3 NO

HYPERICUM PERFORATUM (ST. JOHN'S WORT)

ACTA MEDICA 48:91 2005 22 YRS M NR NR NR 4 NA NO

Page 20: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

IBUPROFEN BMJ 4:430 1969 33 YRS F NR NO NR 5 1 NO

IBUPROFEN J CLIN INVEST 71:413-415 1993 71 YRS F NO YES 2 2 NA NO

IBUPROFEN BR J CLIN PRACT 48:51 1994 55 YRS F NO YES 2 2 NA NO

ILOPROST EUR RESPIR J 36:967-9 2010 63 YRS F NO NO 0 1 NA NO

IMATINIB J TAIBAH UNIV SCI 10:365-8 2015 72 YRS F NO YES 3 2 NA YES

IMIPRAMINE TURK J PEDIATR 51:275-8 2009 5 YRS M NO YES 0 2 NA NO

INAMRINONE NEJM 301:1185 1979 63 YRS M NR YES NR 5 1 NO

INAMRINONE SCAND J HAEMATOL 31:376 1983 NR NR NR NO NR 5 1 NO

INAMRINONE ARCH INTERN MED 144:949-952 1984 NR NR NO NO 0 1 NA NO

INDINAVIR AIDS 10:678-680 1996 41 YRS M NO YES 0 1 NA NO

INDINAVIR AIDS 13:148-149 1999 34 YRS F NO YES 1 1 NA NO

INDINAVIR AIDS PATIENT CARE STDS 17:103-104 2003 53 YRS M NO YES NR 4 NA NO

INDINAVIR INT J INFECT DIS 8:315-316 2004 46 YRS F NO YES 1 1 NA NO

INDOMETHACIN CURR MED RES OPIN 2:600 1974 NR NR NR NO NR 5 1 NO

INDOMETHACIN ACTA HAEMATOL 67:71 1982 80 YRS F NR NO NR 5 1 NO

INDOMETHACIN ACTA HAEMATOL 71:350-352 1984 72 YRS F NO YES 1 2 NA NO

INFLIXIMAB ANN INTERN MED 139:W-W63 2003 60 YRS F NO YES NR 5 7 NO

INFLIXIMAB INFLAMM BOWEL DIS 10:698-700 2004 15 YRS M NO YES 3 4 NA NO

INFLIXIMAB RHEUMATOLOGY 46:1313-4 2006 56 YRS F NO NO 0 5 3 NO

INFLIXIMAB GUT 56:1169-70 2007 42 YRS F NO NO 0 2 NA NO

INFLIXIMAB CLIN RHEUMATOL 26:988-90 2007 30 YRS F NR NR NR 5 2 NO

INFLIXIMAB J AM ACAD DERMATOL 60:781-5 2009 55 YRS M NR NR NR 4 NA NO

INFLIXIMAB J AM ACAD DERMATOL 60:781-5 2009 67 YRS F NO NO 2 4 NA NO

INFLIXIMAB J AM ACAD DERMATOL 60:781-5 2009 41YRS F NR NR 2 4 NA NO

INFLIXIMAB INFLAMM BOWEL DIS 19:E52-3 2013 75 YRS M NO NO 0 2 NA NO

INFLIXIMAB AM J THER 23:E1933-7 2016 30 YRS M NO YES 2 2 NA YES

INFLIXIMAB INT J COLORECTAL DIS 31:921-2 2016 68 YRS F NO YES 2 2 NA YES

INFLIXIMAB CASE REP GASTROENTEROL 10:596-9 2016 34 YRS F NR NR NR 5 2 YES

INFLUENZA VACCINE IMAJ 8:322-323 2006 68 YRS M NO YES 2 2 NA NO

INFLUENZA VACCINE PEDIATRICS 138:E20160124 2016 4.5 YRS M NO YES 1 1 NA YES

INTERFERON ALPHA AM J DIS CHILD 121:43-7 1971 12 YRS M NO NR NR 5 1 NO

INTERFERON ALPHA AM J DIS CHILD 121:43-7 1971 6 YRS F NR NR NR 5 1 NO

INTERFERON ALPHA AM J DIS CHILD 121:43-7 1971 8 YRS M NO YES 3 5 7 NO

Page 21: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

INTERFERON ALPHA JAMA 254:1353-1354 1985 32 YRS F NR NO NR 3 NA NO

INTERFERON ALPHA JAMA 254:1353-1354 1985 35 YRS F NR NO NR 3 NA NO

INTERFERON ALPHA JAMA 254:1353-1354 1985 61 YRS F NR NO NR 3 NA NO

INTERFERON ALPHA JAMA 254:1353-1354 1985 59 YRS F NR NO NR 3 NA NO

INTERFERON ALPHA JAMA 254:1353-1354 1985 40 YRS F NR NO NR 3 NA NO

INTERFERON ALPHA SCAND J HAEMATOL 36:515-519 1986 52 YRS M NO YES 2 1 NA NO

INTERFERON ALPHA BMJ 297:1613 1988 43 YRS F NO YES 1 2 NA NO

INTERFERON ALPHA LANCET 335:970 1990 NR NR NR NO NR 5 1 NO

INTERFERON ALPHA CLIN LAB HAEMATOL 13:315 1991 57 YRS F NR NO NR 5 3 NO

INTERFERON ALPHA JAMA 266:849 1991 NR NR NR NO NR 5 1 NO

INTERFERON ALPHA AM J GASTROENTEROL 87:809-810 1992 44 YRS F NO YES 1 2 NA NO

INTERFERON ALPHA AM J GASTROENTEROL 90:1146-1147 1995 41 YRS M NO YES 2 2 NA NO

INTERFERON ALPHA J HEPATOL 25:972-975 1996 64 YRS F NO YES 0 2 NA NO

INTERFERON ALPHA J HEPATOL 25:972-975 1996 39 YRS M NO YES 0 2 NA NO

INTERFERON ALPHA J HEPATOL 25:270-1 1996 NR NR NO NO 0 5 1 NO

INTERFERON ALPHA HEPATOLOGY 28:1424-1429 1998 NR NR NR NO NR 5 1 NO

INTERFERON ALPHA HEPATOLOGY 28:1430-1432 1998 NR NR NR NO NR 5 1 NO

INTERFERON ALPHA J GASTROENTEROL HEPATOL 15:567-569 2000 50 YRS M NR NO NR 4 NA NO

INTERFERON ALPHA HEPATOGASTROENTEROLOGY 50:841-842 2003 24 YRS F NO YES 0 2 NA NO

INTERFERON ALPHA J VIRAL HEPAT 11:477 2004 20 YRS F NO NO 0 3 NA NO

INTERFERON ALPHA J PEDIATR SURG 41:E29-31 2006 106 DAYS F NO YES NR 5 7 NO

INTERFERON ALPHA INTERN MED 49:1741-4 2010 54 YRS F NO NO NR 2 NA NO

INTERFERON-ALPHA 2a HEPATOGASTROENTEROLOGY 52:1197-2000 2005 47 YRS M NO NO 0 3 NA NO

INTERFERON-ALPHA 2a J INFECT 51:E113-5 2005 73 YRS F NO YES 2 3 NA NO

INTERFERON-ALPHA 2a HEPATOGASTROENTEROLOGY 52:1197-2000 2005 44 YRS F NO NO 0 4 NA NO

INTERFERON-ALPHA 2a WORLD J GASTROENTEROL 16:1414-7 2010 54 YRS F NO YES 2 1 NA NO

INTERFERON-ALPHA 2a DIGESTIVE & LIVER DISEASE 42:233-4 2010 48 YRS M NO YES 0 2 NA NO

INTERFERON-ALPHA 2b LIVER INT 26:1294-7 2006 44 YRS M NO YES 0 3 NA NO

INTRAVENOUS IMMUNOGLOBULIN (IVIG)

TRANSFUSION 58:493-7 2018 80 YRS F NO YES 0 1 NA YES

IOCETAMIC ACID AM J HEMATOL 14:285-288 1983 32 YRS F NO YES 2 2 NA NO

IOCETAMIC ACID AM J HEMATOL 16:103 1984 NR NR NR NO NR 5 1 NO

IOPAMIDOL EUR J CLIN PHARMACOL 54:575-576 1998 NR F NO YES 1 2 NA NO

Page 22: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

IOPAMIDOL OBSTET GYNECOL 121:473-5 2013 22 YRS F NO YES 2 2 NA NO

IOPANOIC ACID JAMA 189:771-772 1964 69 YRS F NR YES NR 3 NA NO

IOPANOIC ACID JAMA 237:361 1977 48 YRS F NO YES 2 1 NA NO

IOPANOIC ACID CLIN TOXICOL 18:221 1981 49 YRS F NO YES 1 2 NA NO

IOVERSOL KOREAN J RADIOL 13: 505-9 2012 72 YRS M NO YES 2 2 NA NO

IPILIMUMAB J ONCOL PHARM PRACT 18: 287-92 2011 57 YRS M NO YES 2 2 NA NO

IPILIMUMAB JPN J CLIN ONCOL 45:381-4 2015 54 YRS NR NO YES 0 2 NA YES

IPILIMUMAB J BUON. 20:1641-2 2015 64 YRS F NO YES 1 3 NA YES

IRINOTECAN ANN ONCOL 9:453-455 1998 53 YRS M NO NO NR 1 NA NO

IRINOTECAN BLOOD 131:1486-9 2018 53 YRS M NR NR NR 1 NA YES

IRON DEXTRAN ACTA HAEMATOL 62:178 1979 35 YRS F NR NO NR 5 2 NO

IRON DEXTRAN ANN INTERN MED 132:925 2000 30 YRS F NO NO 0 2 NA NO

IRON DEXTRAN PDI 23: 408-409 2003 37 YRS F NO YES 1 3 NA NO

ISONIAZID AM REV RESPIR DIS 83:744 1961 25 YRS M NO YES 0 1 NA NO

ISONIAZID INTERN MED 51: 745-8 2012 51 YRS M NO YES 2 2 NA NO

ISONIAZID MULTIDISCIP RESPIR MED 8:1-3 2013 18 YRS F NR NR NR 1 NA NO

ISONIAZID INT J DERMATOL 54:819-22 2015 32 YRS M NO NR NR 4 NA YES

ISOTRETINOIN S AFR MED J 70:705-706 1986 20 YRS NR NO NO 2 2 NA NO

ISOTRETINOIN J AM ACAD DERMATOL 17:838-839 1987 15 YRS NR NO NO 0 1 NA NO

ISOTRETINOIN ANN PHARMACOTHER 37:1622-1624 2003 27 YRS F NO NO 1 3 NA NO

ITRACONAZOLE ANN INTERN MED 125:156-157 1996 54 YRS M NO YES 0 2 NA NO

IXAZOMIB AM J Hematol 92:E53-5 2017 75 YRS F NR NR NR 5 7 YES

JUI LANCET 354: 304-305 1999 51 YRS F YES NO 1 1 NA NO

JUI J THROMB HAEMOST 2: 1479-1480 2004 54 YRS M YES NO 1 1 NA NO

KELP SUPPLMENT TABLET LANCET 339: 1540 1992 54 YRS F NR NO 1 4 NA NO

LAMIVUDINE AM J GASTROENTEROL 97:2687-8 2002 9 YRS M NR NO NR 1 NA NO

LAMOTRIGINE EPILEPTIC DISORD 7:33-35 2005 25 YRS F NO NO 0 5 7 NO

LAMOTRIGINE PSYCHOSOMATICS 47:257-8 2006 40 YRS F NO NO 0 5 7 NO

LAMOTRIGINE J EMERG MED 42:584-5 2012 10 YRS M NO YES 0 2 NA NO

LANSOPRAZOLE ANN PHARMACOTHER 36:809-811 2002 85 YRS M NO YES NR 3 NA NO

LEPIRUDIN AM J HEALTH SYST PHARM 66:834-7 2009 61 YRS M YES YES 3 4 NA NO

LEUCOVORIN BLOOD 131:1486-9 2018 74 YRS F NR NR NR 1 NA YES

LEUCOVORIN BLOOD 131:1486-9 2018 53 YRS M NR NR NR 1 NA YES

Page 23: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

LEVAMISOLE BMJ 2:555-556 1977 59 YRS F NO NO 0 1 NA NO

LEVAMISOLE J OF PEDIATRICS 93:304-5 1978 13 YRS F YES YES NR 5 2 NO

LEVAMISOLE J OF PEDIATRICS 93:304-5 1978 10 YRS F NO NR NR 5 7 NO

LEVAMISOLE J PEDIATR 93:304-305 1978 16 YRS F NO YES 0 5 7 NO

LEVAMISOLE J PEDIATR 93:304-305 1978 10 YRS F NO YES 0 5 7 NO

LEVAMISOLE GASTROENTEROL CLIN BIOL 3:104 1979 20 YRS M NR YES NR 4 NA NO

LEVAMISOLE SOUTH MED J 75:895-896 1982 23 YRS M NR YES NR 4 NA NO

LEVAMISOLE MED PEDIATR ONCOL 24:262-264 1995 55 YRS F NO NO 0 1 NA NO

LEVETIRACETAM EPILEPSIA 45:877-878 2004 49 YRS M NO YES 2 3 NA NO

LEVETIRACETAM EPILEPSY RESEARCH 80:90-92 2008 64 YRS F NR NR NR 2 NA NO

LEVETIRACETAM NEUROPEDIATRICS 40:243-4 2009 6 YRS M NO YES 1 2 NA NO

LEVETIRACETAM EPILEPSY RESEARCH 86:94-6 2009 75 YRS M NR NR NR 5 2 NO

LEVETIRACETAM EPILEPSIA 51:2492-5 2010 35 YRS M NO YES 0 2 NA NO

LEVETIRACETAM EPILEPTIC DISORD 12:335-7 2010 50 YRS F NO NO 0 3 NA NO

LEVETIRACETAM EPILEPTIC DISORD 19:104-8 2017 77 YRS F NO YES NR 3 NA YES

LEVOFLOXACIN J MED ASSOC THAI 92:S69-71 2009 78 YRS M NO YES 2 2 NA NO

LEVOFLOXACIN AM J HEALTH SYST PHARM 68:43-6 2011 73 YRS F NO NO NR 3 NA NO

LEVOFLOXACIN CASE REP MED 2016:2860645 2016 83 YRS M NO YES NR 2 NA YES

LEVOFLOXACIN J PHARM PRACT 31:234-7 2018 76 YRS M NO YES 0 3 NA YES

LIDOCAINE AM J MED SCI 275:365 1978 42 YRS F NR YES NR 3 NA NO

LINCOMYCIN ANN INTERN MED 78:779 1973 56 YRS M NR YES NR 3 NA NO

LINEZOLID JAMA 285:1291 2001 43 YRS F NR NO NR 5 2,3 NO

LINEZOLID JAMA 285:1291 2001 61 YRS F NR NO NR 5 2,3 NO

LINEZOLID JAMA 285:1291 2001 70 YRS M NR NO NR 5 3 NO

LINEZOLID PHARMACOTHERAPY 22:109-112 2002 66 YRS M NR NO NR 5 2,3 NO

LINEZOLID ANN PHARMACOTHER 37:517-520 2003 78 YRS F YES YES NR 5 3 NO

LINEZOLID CID 38:1065-1066 2004 NR NR NR NO NR 5 1,3 NO

LINEZOLID CID 42:1500 2006 NR NR NR NR NR 5 1,3 NO

LINEZOLID INT J ANTIMICROB AGENTS 37:88-9 2011 79 YRS F NR NR NR 5 3 NO

LINEZOLID INT J ANTIMICROB AGENTS 37:88-9 2011 87 YRS M NR NR NR 5 3 NO

LINEZOLID EUR J CLIN PHARMACOL 71:383-5 2015 66 YRS M NR NR NR 5 3,7 YES

LITHIUM AM J HEMATOL 16:313-323 1984 NR NR NR NO NR 5 3 NO

LITHIUM BMJ 305:159 1992 24 YRS F NO YES 0 1 NA NO

Page 24: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

LOPINAVIR/RITONAVIR INT J INFECT DIS 8:315-316 2004 46 YRS F NO YES 1 1 NA NO

LORACARBEF AM J HEMATOL 73:41-43 2003 56 YRS F NO YES 1 3 NA NO

LOSARTAN ANN INTERN MED 137:704 2002 82 YRS F NO NO 2 2 NA NO

LUPINUS TERMIS BEAN J ALLERGY 35: 386-389 1964 13 YRS M YES NO 2 1 NA NO

MEASLES VACCINE AM J DIS CHILD 113:283-285 1967 20 MOS M NO YES 2 5 5 NO

MEASLES VACCINE AM J DIS CHILD 113:534-537 1967 12 MOS F NO YES 0 5 5 NO

MEASLES VACCINE AM J DIS CHILD 113:534-537 1967 21 MOS M NR NR NR 5 5,7 NO

MEASLES VACCINE J IOWA MED SOC 57:1017-1018 1967 31 MOS F NR NO NR 5 5 NO

MEASLES VACCINE AM J DIS CHILD 115:111-113 1968 14 MOS M NO YES 2 5 5 NO

MEASLES VACCINE NEJM 305:225 1981 17 YRS M NR NO NR 5 5 NO

MEASLES, MUMPS, RUBELLA VACCINE (MMR VACCINE)

ACTA PAEDIATR SCAND 72:613-614 1983 20 MOS F NO YES 0 5 5 NO

MEASLES, MUMPS, RUBELLA VACCINE (MMR VACCINE)

J AM BOARD FAM PRACT 9:53-55 1996 12 MOS F NO YES 0 5 5 NO

MEASLES, MUMPS, RUBELLA VACCINE (MMR VACCINE)

PEDIATRICS 97:738-739 1996 9 YRS M NO YES 0 5 5 NO

MEASLES, MUMPS, RUBELLA VACCINE (MMR VACCINE)

EUR J PEDIATR 158:S209-210 1999 11 YRS M NR NO NR 5 1,5 NO

MEASLES, MUMPS, RUBELLA VACCINE (MMR VACCINE)

INDIAN PEDIATR 42:80-2 2005 16 MOS M NO YES 2 5 5 NO

MEASLES-RUBELLA VACCINE VACCINE 29:4878-4880 2011 15 MOS F NO NR NR 5 5 NO

MEBHYDROLIN CLIN EXP DERMATOL 18:131 1993 31 YRS M NO YES 1 2 NA NO

MECLOFENAMATE DICP 15:999 1981 81 YRS F NO YES 1 1 NA NO

MECLOFENAMATE ARTHRITIS RHEUM 25:359-360 1982 80 YRS F NO YES 1 1 NA NO

MEFENAMIC ACID BEITR INFUSIONSTHER TRANSFUSMED 30:413 1992 65 YRS M NR YES NR 3 NA NO

MELOXICAM JAPI 51: 531-532 2003 57 YRS F NO YES 3 2 NA NO

MELOXICAM PHARMACOTHERAPY 34: E14-17 2014 84 YRS F NR NR NR 5 1 NO

MENINGOCOCCAL C VACCINE CLIN EXP RHEUMATOL 35:172 2017 36 YRS F NO NR 2 2 NA YES

MEPROBAMATE AM J MED SCI 262:68-78 1971 54 YRS F NR NO NR 2 NA NO

MEROPENEM TRANSFUSION 57:2715-19 2017 59 YRS M NO YES 2 2 NA YES

MESALAMINE LANCET 337:1297 1991 63 YRS F NR NO NR 5 1 NO

MESALAMINE J CLIN GASTROENTEROL 22:160-161 1996 36 YRS F NR NO NR 5 2 NO

MESALAMINE AM J GASTROENTEROL 94:2304-2306 1999 25 YRS F NO NO 1 1 NA NO

METHAZOLAMIDE DICP 23:58-59 1989 79 YRS M NO NO 0 2 NA NO

Page 25: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

METHICILLIN ANN INTERN MED 85:338-339 1973 41 YRS F NO YES 2 1 NA NO

METHICILLIN ANN INTERN MED 85:338-339 1976 41 YRS F NO YES 2 1 NA NO

METHOTREXATE LANCET 1:621 1970 NR NR NR NO NR 5 3 NO

METHOTREXATE CLIN RHEUMATOL 15:163-167 1996 NR NR NR NO NR 5 1,3 NO

METHOTREXATE CLIN RHEUMATOL 15:266-270 1996 NR NR NR NO NR 5 1,3 NO

METHOTREXATE CLIN RHEUMATOL 16:429-430 1997 64 YRS M NO NO NR 5 3 NO

METHOTREXATE J AM ACAD DERMATOL 39:349-351 1998 36 YRS F NO NO NR 5 3 NO

METHYLDOPA LANCET 2:292 1965 55 YRS F NO YES 1 1 NA NO

METHYLDOPA CAN MED ASSOC J 95:322 1966 41 YRS F NO NO 0 1 NA NO

METHYLDOPA CAN MED ASSOC J 95:322 1966 50 YRS F NR YES NR 3 NA NO

METHYLDOPA BMJ 1:494 1971 64 YRS M NO YES 1 1 NA NO

METHYLDOPA AM J CLIN PATHOL 64:113-115 1975 61 YRS F NO YES 2 2 NA NO

METHYLDOPA NEJM 297:1471 1977 68 YRS F NO YES 1 2 NA NO

METHYLDOPA SOUTH MED J 75:374-375 1982 59 YRS F NO YES 1 2 NA NO

METHYLDOPA AM J MED 85:123 1988 70 YRS F NR YES NR 5 1 NO

METHYLPHENIDATE J FAM PRACT 20:302-304 1985 7 YRS F NO YES 3 4 NA NO

METHYLPHENIDATE ANN PHARMACOTHER 37:1146 2003 10 YRS M NO NO NR 2 NA NO

METHYLPREDNISOLONE BLOOD 115:5431-2 2010 63 YRS M NO YES 2 1 NA NO

METRONIDAZOLE CLIN CASE REP 6:206-8 2018 68 YRS M NO YES 0 3 NA YES

MEXILETINE ARCH INTERN MED 139:246-247 1979 67 YRS M NO YES 1 2 NA NO

MEXILETINE ANN INTERN MED 100:162 1984 53 YRS M NR YES NR 5 2 NO

MEZLOCILLIN REV INFECT DIS 6:13 1984 NR NR NR NO NR 5 1 NO

MEZLOCILLIN REV INFECT DIS 13: 68-72 1991 62 YRS NR NR NR NR 5 7 NO

MEZLOCILLIN REV INFECT DIS 13: 68-72 1991 79 YRS NR NR NR NR 5 7 NO

MEZLOCILLIN ANN INTERN MED 119:862 1993 70 YRS M NR YES NR 3 NA NO

MIANSERIN BR J CLIN PHARMACOL 19:102-104 1985 68 YRS F NR YES NR 3 NA NO

MILK (COW) ARCH DIS CHILD 51: 337-343 1976 0 YRS F YES NO 1 4 NA NO

MILK (COW) LANCET 2: 316 1981 33 YRS M YES NO 3 1 NA NO

MILK (COW) CLIN PEDIATR (PHILA) 52: 985-987 2012 0 YRS M NR NR NR 3 NA NO

MILK (FORMULA) ARCH DIS CHILD 52: 744-745 1977 0 YRS M YES NO 1 4 NA NO

MILTEFOSINE INDIAN J MED RES 126:73-75 2007 29 YRS M NO YES 3 5 1 NO

MILTEFOSINE INDIAN J MED RES 126:73-75 2007 28 YRS F NR NR NR 5 1 NO

MILTEFOSINE INDIAN J MED RES 126:73-75 2007 15 YRS F NO NR 3 5 1 NO

Page 26: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

MILTEFOSINE INDIAN J MED RES 126-73-75 2007 38 YRS M NO NO 3 5 1 NO

MINOCYCLINE J DRUGS DERMATOL 2:320-323 2003 46 YRS M NO YES 1 3 NA NO

MINOXIDIL ANN INTERN MED 92:874 1980 49 YRS M NO YES 2 1 NA NO

MIRTAZAPINE BLOOD CELLS MOL DIS 30:241-245 2003 66 YRS M NO YES 2 2 NA NO

MITOMYCIN AM J MED 116:198-200 2004 47 YRS F NR NO NR 5 3 NO

MORPHINE CLINICAL RESEARCH 27: 744A 1979 23 YRS F NR NR NR 5 1 NO

MORPHINE ARCH INTERN MED 142:832-834 1982 23 YRS F NO YES 1 2 NA NO

MOXALACTAM DICP 18:140-142 1984 84 YRS M NR YES NR 4 NA NO

MOXIFLOXACIN BMJ CASE REP 2013 39 YRS F NO YES 2 2 NA NO

MOXIFLOXACIN ANN PHARMACOTHER 48: 919-22 2014 65 YRS M NO YES 2 2 NA NO

MUROMONAB CD3 NEPHROL DIAL TRANSPLANT 11:2378 1996 63 YRS M NO YES NR 3 NA NO

NADOLOL ANN PHARMACOTHER 39: 555-558 2005 44 YRS F NR NO NR 5 3,7 NO

NAFCILLIN ANTIMICROB AGENTS CHEMOTHER 23:59-62 1983 16 YRS F NR NO NR 5 2 NO

NAFCILLIN ANTIMICROB AGENTS CHEMOTHER 23:59-62 1983 71 YRS F NR NO NR 5 2 NO

NALIDIXIC ACID BMJ 289:962 1984 66 YRS F NO NO 1 1 NA NO

NALIDIXIC ACID BMJ 289:962 1984 75 YRS F NO NO 1 2 NA NO

NALIDIXIC ACID BMJ 289:962 1984 73 YRS F NO NO 1 2 NA NO

NALIDIXIC ACID BMJ 289:962 1984 53 YRS F NO NO 2 2 NA NO

NALIDIXIC ACID BMJ 289:962 1984 81 YRS F NO NO 1 2 NA NO

NALIDIXIC ACID BMJ 289:962 1984 91 YRS M NO NO 0 2 NA NO

NAPHAZOLINE SANG BIOLOGIE PATHOLOGIE 26:115-117 1955 62 YRS F NR NO NR 5 1 NO

NAPHAZOLINE ALLERGY 36:517 1981 21 YRS F NO NO 1 1 NA NO

NAPROXEN AM J HEMATOL 31:74 1989 58 YRS F NO NO 1 2 NA NO

NAPROXEN N Z MED J 108:483-484 1995 23 YRS F NR YES NR 3 NA NO

NAPROXEN BLOOD 97:3846 2001 56 YRS M NR NO NR 2 NA NO

NAPROXEN BLOOD 97:3846 2001 57 YRS M NR NO NR 2 NA NO

NAPROXEN BLOOD 97:3846 2001 71 YRS M NR NO NR 2 NA NO

NIACIN (VITAMIN B3) MAYO CLIN PROC 67: 465-468 1992 51 YRS M NR NO NR 2 NA NO

NIACIN (VITAMIN B3) J CLIN GASTROENTEROL 18: 270-271 1994 32 YRS M NR NO NR 5 2 NO

NICERITROL NEPHRON 86:97 2000 46 YRS F NR NO NR 5 7 NO

NICOTINAMIDE KIDNEY INTL 65:1099-1104 2004 NR NR NR NO NR 3 NA NO

NICOTINAMIDE KIDNEY INTL 68: 2911-2912 2005 NR NR NR NO NR 5 2 NO

NIFEDIPINE POSTGRAD MED J 68:769-770 1992 64 YRS F NR YES NR 3 NA NO

Page 27: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

NIMESULIDE ANN INTERN MED 112:233-34 1990 29 YRS M NO YES 1 2 NA NO

NIMESULIDE EUR J OBSTET GYNECOL REPROD BIOL 108: 97-98

2003 33 YRS F NO YES 0 3 NA NO

NITROFURANTION BMJ CASE REP 2012 56 YRS F NR NR NR 5 7 NO

NITROGLYCERIN BR J DERMATOL 67:299-302 1955 65 YRS M NO YES 1 1 NA NO

NITROPRUSSIDE NEJM 299:1134 1978 NR NR NR NO NR 5 1 NO

NITROPRUSSIDE J HUM HYPERTENS 1:17-18 1987 NR NR NR NO NR 3 NA NO

NONE J THROMB HAEMOST 13:676-8 2015 NR NR NR NR NR 5 1 YES

NONE Journal of Medical Case Reports 10:1-4 2016 4 YRS M NO YES NR 5 1 YES

NONE N ENGL J MED 374:165-73 2016 18 YRS M NR NR NR 5 1 YES

NONE MEDICINE (UK) 45:221-4 2017 NR NR NR NR NR 5 1 YES

OCTREOTIDE SOUTH MED J 83:77 1990 39 YRS M NR NO NR 5 3 NO

OCTREOTIDE AM J MED SCI 320:296-297 2000 42 YRS F NO YES 0 1 NA NO

OCTREOTIDE EUR J GASTROENTEROL HEPATOL 21:384-385 2009 53 YRS M NO YES 2 1 NA NO

OFATUMUMAB N ENGL J MED 378:92-3 2018 NR NR NR NR NR 5 7 YES

OLANZAPINE BR J PSYCHIATRY 173:352 1998 30 YRS F NO YES NR 3 NA NO

OLANZAPINE PSYCHOSOMATICS 41:277 2000 38 YRS F NO YES NR 4 NA NO

OLANZAPINE ARCH GEN PSYCH 58:7067 2001 50 YRS F NR NO NR 5 1,7 NO

OLANZAPINE EUR J CLIN PHARMACOL 60:295-296 2004 78 YRS M NO YES 2 5 1 NO

OLANZAPINE J MSMA 45: 363-367 2004 88 YRS F NR NR NR 5 2 NO

OLANZAPINE J CLIN PSYCHOPHARMACOL 32:132-3 2012 27 YRS F NR NR NR 5 7 NO

OLMESARTAN HELLENIC J CARDIOL 58:96-7 2017 70 YRS M NO YES 3 5 7 YES

ONDANSETRON ANN ONCOL 3:719 1992 57 YRS M NR NO NR 4 NA NO

ONDANSETRON ANN ONCOL 3:719 1992 59 YRS M NR NO NR 4 NA NO

ONDANSETRON ANN ONCOL 3:719 1992 26 YRS M NR NO NR 5 3 NO

ONDANSETRON ANN ONCOL 3:773 1992 NR NR NR NO NR 5 1 NO

ONDANSETRON ANN ONCOL 5:98 1994 23 YRS F NR NO NR 4 NA NO

ONDANSETRON ANN ONCOL 5:98 1994 35 YRS M NR NO NR 4 NA NO

ONDANSETRON BLOOD 131:1486-9 2018 53 YRS M NR NR NR 1 NA YES

OSELTAMIVIR/PROBENECID PHARMACOTHERAPY 29:988-92 2009 68 YRS F NO YES 0 2 NA NO

OXALIPLATIN ACTA ONCOL 40:882-883 2001 52 YRS M NR NO NR 5 3,7 NO

OXALIPLATIN ANN INTERN MED 139:E156 2003 70 YRS F NR NO 1 3 NA NO

OXALIPLATIN ONCOLOGY 67:179-182 2004 60 YRS M NO YES 2 3 NA NO

Page 28: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

OXALIPLATIN ASIA-PACIFIC J CLIN ONCOL 1:57-60 2005 52 YRS M NO YES 3 5 1 NO

OXALIPLATIN TRANSFUSION 45:704-708 2005 79 YRS F NR NO NR 5 7 NO

OXALIPLATIN AM J HEMATOL 81:193-198 2006 38 YRS F YES YES 3 2 NA NO

OXALIPLATIN GASTROENTEROL CLIN BIOL 30:797-798 2006 59 YRS F NO YES 2 2 NA NO

OXALIPLATIN AM J HEMATOL 81:193-198 2006 55 YRS F NO YES 3 3 NA NO

OXALIPLATIN CANCER CHEMOTHER PHARMACOL 62:925-7 2008 83 YRS F NO YES 0 2 NA NO

OXALIPLATIN ACTA ONCOL 47:1602-4 2008 44 YRS F NO YES 2 3 NA NO

OXALIPLATIN ANTICANCER RES 28:3115-7 2008 64 YRS M YES YES 3 3 NA NO

OXALIPLATIN CANCER CHEMOTHER PHARMACOL 62:925-7 2008 74 YRS F NO YES 3 3 NA NO

OXALIPLATIN CLIN COLORECTAL CANCER 8:220-4 2009 60 YRS F NO YES 3 3 NA NO

OXALIPLATIN J ONCOL PHARM PRACT 17:433-5 2010 68 YRS M NO NO 2 1 NA NO

OXALIPLATIN TUMORI 96:154-6 2010 55 YRS F NO YES 2 3 NA NO

OXALIPLATIN TRANSFUSION 50:1453-9 2010 76 YRS F NO YES 3 5 7 NO

OXALIPLATIN CARDIOVASC INTERVENT RADIOL 34:S190-4 2011 51 YRS M NO NO 0 1 NA NO

OXALIPLATIN CARDIOVASC INTERVENT RADIOL 34:S190-4 2011 51 YRS M NO NO 0 1 NA NO

OXALIPLATIN AM SURG 77:E9 2011 59 YRS F NR YES NR 3 NA NO

OXALIPLATIN J ONCOL PHARM PRACT 21:148-56 2015 63 YRS M NR YES NR 3 NA YES

OXALIPLATIN J ONCOLOGICAL SCI 3:18-21 2017 56 YRS F NR NR NR 3 NA YES

OXALIPLATIN BLOOD 131:1486-9 2018 74 YRS F NR NR NR 1 NA YES

OXALIPLATIN BLOOD 131:1486-9 2018 53 YRS M NR NR NR 1 NA YES

OXCARBAZEPINE PSYCHOSOMATICS 47:73-74 2006 63 YRS F NO YES NR 2 NA NO

OXCARBAZEPINE J CLIN PSYCHOPHARMACOLOGY 31:137-8 2011 10 YRS M NO YES 0 4 NA NO

OXPRENOLOL LANCET 2:683 1978 57 YRS M NO YES 2 1 NA NO

OXPRENOLOL MED J AUST 2:259 1979 61 YRS M NO YES 1 2 NA NO

OXPRENOLOL ACTA HAEMATOL 68:75 1982 55 YRS M NO YES 1 1 NA NO

OXYPHENBUTAZONE JAMA 175:614-615 1961 64 YRS F NO YES 2 2 NA NO

OXYPHENBUTAZONE LANCET 1:245-246 1971 17 YRS F NO YES 2 2 NA NO

OXYPHENBUTAZONE CHEST 79:358-359 1981 71 YRS F NR YES NR 4 NA NO

OXYTETRACYCLINE LANCET 1:1053-1054 1955 77 YRS M NR YES NR 4 NA NO

OXYTETRACYCLINE AM J HEMATOL 43:333-334 1993 41 YRS F NO YES 1 2 NA NO

PANTOPRAZOLE ANN PHARMACOTHER 40:758-761 2006 62 YRS F NO NO 0 3 NA NO

PANTOPRAZOLE ANN PHARMACOTHER 40:758-761 2006 42 YRS M NO YES 0 3 NA NO

PANTOPRAZOLE INDIAN J PEDIATR 76:1278-9 2009 26 DAYS F NO YES NR 3 NA NO

Page 29: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

PANTOPRAZOLE BLOOD COAGUL FIBRINOLYSIS 24: 351-4 2013 98 YRS M NO YES 0 2 NA NO

PAPAVERINE J NEUROSURG 83:435-437 1995 70 YRS M NR YES NR 3 NA NO

PEGINTERFERON ALFA 2B AM J GASTROENTEROL 98:706-707 2003 38 YRS F NO YES 1 2 NA NO

PEGINTERFERON ALFA 2B/ RIBAVIRIN

AM J HEMATOL 78:138-141 2005 43 YRS F NR NO NR 4 NA NO

PEGINTERFERON ALFA 2B/ RIBAVIRIN

PLATELETS 17:340-3 2006 40 YRS F NR YES 2 3 NA NO

PEGINTERFERON ALFA 2B/ RIBAVIRIN

J GASTROENTEROL HEPATOL 21:622-3 2006 27 YRS M NO NO 0 4 NA NO

PENICILLAMINE SOUTH MED J 68:113-115 1975 52 YRS F NO YES 1 5 3 NO

PENICILLAMINE INTERN MED 31:244-245 1992 47 YRS F NR YES NR 5 3 NO

PENICILLIN ANN MED INTERN FENN 36:531-535 1947 69 YRS M NO YES 3 2 NA NO

PENICILLIN CHIN MED J 85:249-251 1966 29 YRS M NR NO NR 4 NA NO

PENICILLIN NEJM 274:171-178 1966 NR NR NR NO NR 5 2 NO

PENICILLIN MED CLIN NORTH AM 56:65-79 1972 55 YRS M NO YES 2 1 NA NO

PENICILLIN BR J HAEMATOL 55:155-160 1983 47 YRS M NR NO NR 5 1 NO

PENICILLIN TRANSFUSION 24:395-398 1984 74 YRS F NR NO NR 3 NA NO

PENTAGASTRIN LANCET 2:1068-1069 1985 46 YRS F NR NO NR 5 1 NO

PENTAMIDINE CANCER 34:441 1974 23 YRS F NR YES NR 3 NA NO

PENTOSTATIN AM J HEMATOL 73:37-40 2003 45 YRS M NO NO NR 5 3 NO

PENTOXIFYLLINE INT J DERMATOL 36:634-639 1997 NR NR NO NO 0 1 NA NO

PENTOXIFYLLINE J PED SURGERY 41:E29-31 2006 107 days NR NO YES 0 5 7 NO

PENTOXIFYLLINE J PHARM PRACT 28:572-6 2015 72 YRS M NO YES NR 3 NA YES

PERAMIVIR INTERN MED 54:1575 2015 NR NR NR NR NR 5 1 YES

PHENOBARBITAL N Y STATE J MED 36:491-494 1936 52 YRS F NR NO NR 3 NA NO

PHENOBARBITAL ANN PHARMACOTHER 44:2031-4 2010 45 YRS F NO NO 0 1 NA NO

PHENYLBUTAZONE JAMA 150:1084 1952 NR NR NR NO NR 5 1 NO

PHENYTOIN J PEDIATR 43:43-46 1953 9 YRS F NR NO NR 4 NA NO

PHENYTOIN JAMA 180:528-532 1962 39 YRS F NR YES NR 4 NA NO

PHENYTOIN NEUROLOGY 24:1178-1180 1974 26 YRS F NR NO NR 4 NA NO

PHENYTOIN AM J HEMATOL 2:65-72 1977 46 YRS M NR YES NR 3 NA NO

PHENYTOIN ANN NEUROL 6:370 1979 46 YRS NR NO YES 2 2 NA NO

PHENYTOIN N Y STATE J MED 81:1085-1087 1981 43 YRS F NR YES NR 4 NA NO

Page 30: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

PHENYTOIN BIRTH DEFECTS ORIG ARTIC SER 18:47-50 1982 7 HRS F NO YES 3 5 8 NO

PHENYTOIN BIRTH DEFECTS ORIG ARTIC SER 18:47-50 1982 22 DAYS M NO YES 3 5 8 NO

PHENYTOIN SURG NEUROL 23:169-172 1985 67 YRS M NR YES NR 3 NA NO

PHENYTOIN PEDIATR NEUROL 2:99-101 1986 15 YRS M NO YES 2 2 NA NO

PHENYTOIN NEUROSURGERY 20:963-965 1987 68 YRS M NR NO NR 3 NA NO

PHENYTOIN CLIN PHARM 8:734 1989 17 YRS M NO YES 1 2 NA NO

PHENYTOIN J EPILEPSY 5:186-190 1992 NR NR NR NO NR 5 1 NO

PHENYTOIN J INTERN MED 234:91-94 1993 81 YRS F NR NO NR 4 NA NO

PHENYTOIN EPILEPSIA 34:1098-101 1993 NR NR NR NO NR 5 1 NO

PHENYTOIN J CHILD NEUROL 9:311-314 1994 NR NR NR NO NR 5 1 NO

PHENYTOIN ANN PHARMACOTHER 31:435-437 1997 58 YRS M NR NO NR 3 NA NO

PHENYTOIN J PEDIATR HEMATOL ONCOL 20:152-153 1998 8 YRS F NO YES NR 2 NA NO

PHENYTOIN CLEVE CLIN J MED 65:209-214 1998 61 YRS F YES YES NR 5 7 NO

PHENYTOIN J CHILD NEUROL 14:130-1 1999 2 YRS F NO YES 2 2 NA NO

PHENYTOIN EUR J ANAESTHESIOL 24:889-901 2007 66 YRS F YES YES 3 2 NA NO

PHENYTOIN J PHARM PRACT 23:140-3 2010 55 YRS M NO YES 0 3 NA NO

PHENYTOIN BLOOD COAGUL FIBRINOLYSIS 23:778-80 2012 57 YRS F NO YES 2 2 NA NO

PIOGLITAZONE ANN INTERN MED 143:465-466 2005 50 YRS F NR NO NR 5 2,7 NO

PIPERACILLIN REV INFECT DIS 13: 68-72 1991 88 YRS NR NR NR NR 5 1 NO

PIPERACILLIN SCAN J INFECT DIS 24:815-7 1992 71 YRS M NR NR NR 1 NA NO

PIPERACILLIN SCAND J INFECT DIS 24:815-817 1992 71 YRS M NO YES 2 1 NA NO

PIPERACILLIN AM J HEMATOL 85:71-4 2010 30 YRS M NO YES 0 1 NA NO

PIPERACILLIN PLATELETS 22:294-301 2011 54 YRS M NR NR NR 2 NA NO

PIPERACILLIN BMJ CASE REP 2012 48 YRS F NR NR NR 3 NA NO

PIPERACILLIN HEMODIAL INT 16:S50-3 2012 74 YRS F NR NR NR 3 NA NO

PIPERACILLIN/TAZOBACTAM CLIN INFECT DIS 27:650-651 1998 69 YRS F NO YES 1 2 NA NO

PIPERACILLIN/TAZOBACTAM CLIN NEPHROL 72:240-3 2009 78 YRS M NO YES 0 2 NA NO

PIPERACILLIN/TAZOBACTAM PHARMACOTHERAPY 35:E326-30 2015 69 YRS M NR YES 0 1 NA YES

PIPERACILLIN/TAZOBACTAM J PHARM PRACT 28:204-6 2015 64 YRS M NR YES NR 1 NA YES

PIPERACILLIN/TAZOBACTAM J PHARM PRACT 28:204-6 2015 55 YRS F NO YES 0 2 NA YES

PIPERACILLIN/TAZOBACTAM J CLIN PHARM THER 41:730-2 2016 47 YRS F NO YES 0 1 NA YES

PIPERACILLIN/TAZOBACTAM EXP THER MED 11:1223-6 2016 76 YRS M NO YES NR 5 1 YES

PIPERAZINE BMJ 301:1398 1990 61 YRS M NO NO 2 2 NA NO

Page 31: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

PIRACETAM EPILEPTIC DISORD 13:226 2011 69 YRS M NO NO NR 4 NA NO

PIROXICAM BR J CLIN PRACT 40:42 1986 81 YRS M NR NO NR 4 NA NO

PIROXICAM CLIN EXP RHEUMATOL 5:298-300 1987 69 YRS F NR YES NR 3 NA NO

PLICAMYCIN ANN PHARMACOTHER 26:1369-1373 1992 73 YRS M NR YES NR 4 NA NO

PODOPHYLLUM ANN INTERN MED 89:362-363 1978 15 YRS F NO YES 2 5 3 NO

POTASSIUM IODIDE ARCH DERMATOL SYPH 53:644 1946 48 YRS M NR NO NR 5 2 NO

POTATO J ALLERGY CLIN IMMUNOL 8: 143-154 1937 12 YRS F YES NO 3 3 NA NO

POTATO AND MILK J ALLERGY CLIN IMMUNOL 8: 143-154 1937 26 YRS F YES NO 3 3 NA NO

PREDNISONE NEJM 265:611-617 1961 24 YRS M NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 53 YRS M NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 27 YRS F NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 63 YRS F NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 26 YRS F NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 46 YRS F NR YES NR 4 NA NO

PREDNISONE NEJM 265:611-617 1961 58 YRS F NR YES NR 4 NA NO

PREDNISONE PAC MED SURG 75:33-34 1967 2 YRS M NR NO NR 4 NA NO

PREDNISONE J GERONTOL A BIOL SCI MED SCI 57:M519-22 2002 83 YRS F NR NO NR 5 1 NO

PRIMIDONE ANN INTERN MED 81:559-560 1974 26 YRS F NO YES 0 2 NA NO

PROCAINAMIDE J KANSAS MED SOC 67:20 1966 70 YRS M NR YES NR 4 NA NO

PROCAINAMIDE JAMA 235:2520-2521 1976 73 YRS F NR YES NR 3 NA NO

PROCAINAMIDE ANN INTERN MED 100:918 1984 75 YRS M NR YES NR 3 NA NO

PROCAINAMIDE AM J HEMATOL 16:181-183 1984 81 YRS F NR YES NR 4 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 53 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 72 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 61 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 77 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 41 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ARCH INTERN MED 145:700-702 1985 42 YRS NR NO NO 0 2 NA NO

PROCAINAMIDE ANN PHARMACOTHER 28:1172-1176 1994 77 YRS M NR YES NR 3 NA NO

PROCAINAMIDE AM J HEMATOL 48:133-134 1995 68 YRS M NO YES 0 2 NA NO

PROCHLOPERAZINE AM J CLIN PATHOL 40:284 1963 73 YRS F NR YES NR 4 NA NO

PROPYLTHIOURACIL JAMA 143:891 1950 50 YRS M NR YES NR 3 NA NO

PROTAMINE SULPHATE THROMB HAEMOST 53:60-64 1985 NR NR NR NO NR 5 1 NO

Page 32: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

PROTAMINE SULPHATE TRANSFUSION 53: 2158-63 2013 75 YRS F NR NR NR 3 NA NO

PYRAZINAMIDE CHEST 57:378-381 1970 19 YRS F NO YES 0 2 NA NO

PYRAZINAMIDE DRUG WATCH 45:405-7 2013 32 YRS M NO YES 2 1 NA NO

PYRAZINAMIDE INT J DERMATOL 54:819-22 2015 32 YRS M NO NR NR 1 NA YES

PYRIMETHAMINE MILITARY MED 138:280-283 1973 21 YRS M NR NO NR 4 NA NO

PYRIMETHAMINE AM J OPHTHALMOL 93:371 1982 30 YRS F NR NO NR 5 1 NO

QUETIAPINE PSYCHOSOMATICS 48:530-1 2007 45 YRS M NR NR NR 5 2 NO

QUETIAPINE J CHILD ADOLESC PSYCHOPHARMACOL 20:453-5

2010 16 YRS F NO YES 0 2 NA NO

QUETIAPINE BRAZ J PSYCHIATR 37:351 2015 78 YRS M NO YES NR 3 NA YES

QUETIAPINE BRAZ J PSYCHIATR 37:351 2015 72 YRS F NO YES NR 3 NA YES

QUETIAPINE BMC PSYCHIATRY 15:110 2015 23 YRS M NR YES NR 4 NA YES

QUETIAPINE KLINIK PSIKOFARMAKOL BULTENI 26:319-23 2016 69 YRS M NO YES NR 1 NA YES

QUINIDINE JAMA 137:1219 1948 57 YRS F NO YES 1 1 NA NO

QUINIDINE CAN MED ASSOC J 60:508 1949 35 YRS F NO YES 2 1 NA NO

QUINIDINE AM HEART J 39:303 1950 76 YRS F NO YES 2 1 NA NO

QUINIDINE AM HEART J 39:303 1950 50 YRS F NO NO 1 1 NA NO

QUINIDINE AM J MED 9:828 1950 58 YRS F NO NO 2 1 NA NO

QUINIDINE BMJ 1:553 1950 48 YRS F NO NO 2 1 NA NO

QUINIDINE CIRCULATION 2:438-440 1950 27 YRS F NO YES 1 1 NA NO

QUINIDINE CIRCULATION 2:438-440 1950 57 YRS F NO NO 1 1 NA NO

QUINIDINE CIRCULATION 2:438-440 1950 35 YRS F NO NO 2 1 NA NO

QUINIDINE CIRCULATION 2:438-440 1950 76 YRS F NO NO 1 1 NA NO

QUINIDINE NEJM 242:53 1950 66 YRS F NO YES 3 1 NA NO

QUINIDINE ANN INTERN MED 37:190 1952 65 YRS M NO NO 1 1 NA NO

QUINIDINE AM J MED SCI 224:274 1952 63 YRS F NO YES 2 2 NA NO

QUINIDINE AM J MED SCI 224:274 1952 56 YRS F NR YES NR 3 NA NO

QUINIDINE BLOOD 8:16 1953 61 YRS F NO YES 1 1 NA NO

QUINIDINE J CLIN PATHOL 6:320 1953 63 YRS F NR YES NR 4 NA NO

QUINIDINE AM J MED 17:414-422 1954 70 YRS F NR YES 2 1 NA NO

QUINIDINE BLOOD 9:1 1954 53 YRS F NO NO 2 1 NA NO

QUINIDINE BLOOD 9:134 1954 53 YRS F NO YES 0 1 NA NO

QUINIDINE J LAB CLIN MED 48:205-217 1956 78 YRS F NO YES 2 1 NA NO

Page 33: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

QUINIDINE J LAB CLIN MED 48:205-217 1956 39 YRS M NO YES 1 1 NA NO

QUINIDINE ACTA MED SCAND 154:289-298 1956 24 YRS M NO NO 1 2 NA NO

QUINIDINE BLOOD 11:527-546 1956 57 YRS F NO NO 3 2 NA NO

QUINIDINE BLOOD 11:527-546 1956 61 YRS F NO YES 1 2 NA NO

QUINIDINE BLOOD 11:527-546 1956 57 YRS F NO YES 3 2 NA NO

QUINIDINE BLOOD 11:527-546 1956 51 YRS M NO YES 2 2 NA NO

QUINIDINE J LAB CLIN MED 48:205-217 1956 69 YRS M NO YES 1 2 NA NO

QUINIDINE J LAB CLIN MED 48:205-217 1956 76 YRS F NO YES 2 2 NA NO

QUINIDINE J LAB CLIN MED 48:205-217 1956 54 YRS F NO YES 1 2 NA NO

QUINIDINE J LAB CLIN MED 48:205-217 1956 70 YRS F NO YES 1 2 NA NO

QUINIDINE BLOOD 11:527-546 1956 65 YRS F NR NO NR 3 NA NO

QUINIDINE BLOOD 11:547 1956 NR NR NR NO NR 5 1 NO

QUINIDINE BMJ 1:1046 1957 40 YRS M NR YES 3 2 NA NO

QUINIDINE J EXP MED 107:711-729 1958 74 YRS F NO YES 1 1 NA NO

QUINIDINE J EXP MED 107:711-729 1958 62 YRS F NO NO 1 1 NA NO

QUINIDINE BMJ 2:1502 1958 50 YRS M NO NO 2 2 NA NO

QUINIDINE ANN INTERN MED 56:618 1962 76 YRS F NR YES 2 2 NA NO

QUINIDINE JAMA 180:528-532 1962 82 YRS M NR YES NR 3 NA NO

QUINIDINE CALIFORNIA MED 102:310 1965 82 YRS F NR YES 2 1 NA NO

QUINIDINE CALIFORNIA MED 102:310 1965 73 YRS M NO YES 3 1 NA NO

QUINIDINE CALIFORNIA MED 102:310 1965 79 YRS M NO YES 1 2 NA NO

QUINIDINE LANCET 2:36 1965 48 YRS F NR YES NR 5 7 NO

QUINIDINE TRANSFUSION 5:336-343 1965 NR NR NR NO NR 5 1 NO

QUINIDINE AM J MED SCI 262:68-78 1971 55 YRS F NO NO NR 1 NA NO

QUINIDINE AM J MED SCI 262:68-78 1971 48 YRS F NR NO NR 2 NA NO

QUINIDINE PROC R SOC MED 65:590-593 1972 78 YRS F NO YES 1 1 NA NO

QUINIDINE MED CLIN NORTH AM 56:65-79 1972 71 YRS M NO YES 2 2 NA NO

QUINIDINE MED CLIN NORTH AM 56:65-79 1972 58 YRS M YES YES 3 5 1 NO

QUINIDINE NEJM 287:408 1972 NR NR NR NO NR 5 1 NO

QUINIDINE NEJM 296:572 1977 70 YRS M NO YES 0 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 25:53-59 1977 57 YRS M NR YES NR 3 NA NO

QUINIDINE HENRY FORD HOSP MED J 25:53-59 1977 61 YRS M NR YES NR 4 NA NO

QUINIDINE HENRY FORD HOSP MED J 25:53-59 1977 64 YRS F NR YES NR 4 NA NO

Page 34: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

QUINIDINE HENRY FORD HOSP MED J 25:53-59 1977 73 YRS F NR YES NR 5 1 NO

QUINIDINE J LAB CLIN MED 89:400 1977 NR NR NR NO NR 5 1 NO

QUINIDINE BLOOD 53:396-402 1979 72 YRS M NO YES 1 2 NA NO

QUINIDINE J IOWA MED SOC 69:315-317 1979 43 YRS F NR YES NR 3 NA NO

QUINIDINE ARCH INTERN MED 140:266-267 1980 79 YRS M NO YES 2 2 NA NO

QUINIDINE AM J HEMATOL 9:439-446 1980 NR NR NR NO NR 5 1 NO

QUINIDINE ARCH INTERN MED 140:1250-1251 1980 71 YRS M NR NO NR 5 1 NO

QUINIDINE CLIN HAEMATOL 9:505-519 1980 NR NR NR NO NR 5 1 NO

QUINIDINE CLIN CARDIOL 4:247 1981 62 YRS M NO YES 1 2 NA NO

QUINIDINE ORAL SURG 51:478-480 1981 62 YRS M NO YES 2 2 NA NO

QUINIDINE SOUTH MED J 75:514 1982 NR NR NR NO NR 5 1 NO

QUINIDINE JAMA 252:3257-3260 1984 58 YRS F NR NO NR 1 NA NO

QUINIDINE JAMA 252:3257-3260 1984 58 YRS F NR NO NR 2 NA NO

QUINIDINE JAMA 252:3257-3260 1984 58 YRS M NR NO NR 2 NA NO

QUINIDINE JAMA 252:3257-3260 1984 66 YRS M NR NO NR 2 NA NO

QUINIDINE JAMA 252:3257-3260 1984 45 YRS M NR NO NR 2 NA NO

QUINIDINE J LAB CLIN MED 104:730-740 1984 NR NR NR NO NR 5 1 NO

QUINIDINE JAMA 252:3257-3260 1984 74 YRS M NR NO NR 5 1 NO

QUINIDINE JAMA 252:3257-3260 1984 58 YRS M NR NO NR 5 7 NO

QUINIDINE JAMA 252:3257-3260 1984 82 YRS F NR NO NR 5 7 NO

QUINIDINE JAMA 252:3257-3260 1984 62 YRS M NR NO NR 5 7 NO

QUINIDINE JAMA 252:3257-3260 1984 53 YRS F NR NO NR 5 7 NO

QUINIDINE AM J MED 79:253 1985 24 YRS F NO NO 1 2 NA NO

QUINIDINE J CLIN INVEST 75:310-314 1985 NR NR NR NO NR 5 1 NO

QUINIDINE CURR STUD HEMATOL BLOOD TRANSFUS 52:104-114

1986 NR NR NR NO NR 5 1 NO

QUINIDINE BR J HAEMATOL 67:213 1987 NR NR NR NO NR 5 1 NO

QUINIDINE J CLIN INVEST 79:912 1987 NR NR NR NO NR 5 1 NO

QUINIDINE ANN INTERN MED 108:206-208 1988 63 YRS M NR NO NR 5 1 NO

QUINIDINE ANN INTERN MED 108:206-208 1988 61 YRS F NR NO NR 5 1 NO

QUINIDINE ANN INTERN MED 108:206-208 1988 73 YRS F NR NO NR 5 1 NO

QUINIDINE CURR STUD HEMATOL BLOOD TRANSFUS 54:71-88

1988 NR NR NR NO NR 5 1 NO

Page 35: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 58 YRS M NO NO 1 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 64 YRS M NO NO 1 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 62 YRS M NO NO 1 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 75 YRS F NO NO 0 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 65 YRS F NO NO 1 2 NA NO

QUINIDINE HENRY FORD HOSP MED J 37:28-32 1989 72 YRS M NO NO 1 2 NA NO

QUINIDINE CLIN PHARM 8:89 1989 91 YRS F NR YES NR 4 NA NO

QUINIDINE ALA MED 59:21-25 1989 76 YRS F NR NO NR 5 1 NO

QUINIDINE DICP 24:693-694 1990 61 YRS M NR YES NR 3 NA NO

QUINIDINE TRANSFUS MED REV 4:69 1990 NR NR NR NO NR 5 1 NO

QUINIDINE BR J HAEMATOL 80:77-82 1992 NR NR NR NO NR 5 1 NO

QUINIDINE TRANSFUSION MED REV 7:275 1993 NR NR NR NO NR 5 1 NO

QUINIDINE NEJM 332:1363 1995 70 YRS F NR YES NR 4 NA NO

QUINIDINE CUTIS 62:193-195 1998 64 YRS M NO YES 1 2 NA NO

QUINIDINE SEMIN HEMATOL 37:229-238 2000 77 YRS M NO YES 2 4 NA NO

QUINIDINE ARCH INTERN MED 164:218-220 2004 72 YRS F NO YES 2 1 NA NO

QUININE LANCET 2:37 1865 50 YRS F NO YES 2 1 NA NO

QUININE LANCET 2:37 1865 ADULT F NO YES 2 2 NA NO

QUININE LANCET 2:37 1865 12 YRS M NO YES 2 2 NA NO

QUININE LANCET 2:37 1865 ADULT M NR NO 0 3 NA NO

QUININE BOSTON MED SURG J 109:587 1883 52 YRS F NR NO NR 5 1 NO

QUININE BOSTON MED SURG J 137:646 1897 29 YRS M NO NO 2 5 1 NO

QUININE TROP DIS BULL 12:350 1918 NR NR NR NO NR 5 1 NO

QUININE J LAB CLIN MED 13:303-321 1928 NR NR NR NO NR 1 NA NO

QUININE J LAB CLIN MED 8:303 1928 NR NR NR NO NR 5 1 NO

QUININE TROP DIS BULL 28:849 1931 NR M NR NO NR 5 1 NO

QUININE ACTA MED SCAND 131 (S213):165-170 1948 25 YRS F NO YES 1 1 NA NO

QUININE AM PRACT DIG TREAT 3:43-45 1952 28 YRS M NO YES 3 1 NA NO

QUININE J CLIN PATHOL 6:320 1953 19 YRS F NO YES 1 1 NA NO

QUININE J LAB CLIN MED 45:18 1955 31 YRS F NO NO 2 1 NA NO

QUININE PEDIATRICS 19:84-87 1957 30 YRS F NO YES 3 2 NA NO

QUININE PEDIATRICS 19:84-87 1957 1 DAY F NO YES 0 5 8 NO

QUININE ORAL SURG 12:692-695 1959 27 YRS F NR YES NR 3 NA NO

Page 36: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

QUININE JAMA 180:528-532 1962 20 YRS F NR YES NR 3 NA NO

QUININE ANN INTERN MED 66:583-586 1967 23 YRS F NO YES 2 2 NA NO

QUININE ARCH INTERN MED 120:59-62 1967 20 YRS F NO YES 2 2 NA NO

QUININE MED J AUST 1:453-456 1969 16 YRS F NO YES 2 2 NA NO

QUININE ROCKY MOUNTAIN MED J 70:38-41 1973 34 YRS F YES NO NR 1 NA NO

QUININE ROCKY MOUNTAIN MED J 70:38-41 1973 22 YRS M NR NO NR 2 NA NO

QUININE J ORAL SURG 34:272-275 1976 65 YRS M NR YES NR 3 NA NO

QUININE BMJ 2:1551-1552 1979 16 YRS F NO YES 2 1 NA NO

QUININE ARCH INTERN MED 143:1174-1175 1983 22 YRS M NR NO NR 3 NA NO

QUININE ORAL SURG 55:351-354 1983 71 YRS F NR YES NR 3 NA NO

QUININE JAMA 252:3257-3260 1984 70 YRS F NR NO NR 2 NA NO

QUININE AM J MED 80:1051 1986 67 YRS F NR NO NR 5 1 NO

QUININE AM J MED 80:1051 1986 88 YRS F NR NO NR 5 1 NO

QUININE AM J MED 80:1051 1986 77 YRS F NR NO NR 5 1 NO

QUININE AM J MED 80:1051 1986 70 YRS M NR NO NR 5 1 NO

QUININE AM J MED 80:1051 1986 74 YRS F NR NO NR 5 1 NO

QUININE ARCH OPHTHALMOL 105:1176 1987 66 YRS M NR YES NR 3 NA NO

QUININE J BONE JOINT SURG 70:1097-1099 1988 26 YRS M NO YES 2 2 NA NO

QUININE AUST ADVERSE DRUG REACTION BULLETIN 1988 NR NR NR NO NR 5 1 NO

QUININE ANN INTERN MED 112:308-309 1990 41 YRS F YES YES 3 1 NA NO

QUININE ANN INTERN MED 112:308-309 1990 39 YRS M YES YES 3 2 NA NO

QUININE BMJ 301: 333 1990 63 YRS F YES NO 1 3 NA NO

QUININE ARCH INTERN MED 151:1021 1991 NR NR NR NO NR 5 1 NO

QUININE BLOOD 77:306-310 1991 51 YRS F NR YES NR 5 1,7 NO

QUININE BLOOD 77:306-310 1991 21 YRS M NR YES NR 5 7 NO

QUININE BLOOD 77:306-310 1991 66 YRS M NR YES NR 5 7 NO

QUININE BLOOD 80:241-248 1992 23 YRS F NR NO NR 5 7 NO

QUININE BLOOD 80:2686 1992 20 YRS M NR YES 1 5 7 NO

QUININE AM J HEMATOL 47:283-289 1994 NR NR NR NO NR 5 1,3 NO

QUININE BR J DERMATOL 131: 734-735 1994 59 YRS F NO NO 1 5 1 NO

QUININE EUR J HAEMATOL 57:64-68 1996 NR NR NR NO NR 5 1 NO

QUININE J INTERN MED 239:509-515 1996 NR NR NR NO NR 5 1 NO

QUININE BLOOD 90:4806-4811 1997 58 YRS M NO YES 0 1 NA NO

Page 37: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

QUININE MED J AUST 168:19-20 1998 57 YRS M NO YES 2 1 NA NO

QUININE AUST FAM PHYSICIAN 27:922-923 1998 64 YRS M NO YES 1 2 NA NO

QUININE CUTIS 62:193-195 1998 46 YRS M NO YES 1 2 NA NO

QUININE AM J KIDNEY DIS 33: 133-137 1999 62 YRS M NR NR NR 5 7 NO

QUININE J OKLA STATE MED ASSOC 93:519 2000 68 YRS M NO YES 2 1 NA NO

QUININE AUST DENT J 45:282 2000 67 YRS M NO YES 3 4 NA NO

QUININE AUST N Z J MED 30:96 2000 40 YRS F NR NO NR 5 7 NO

QUININE MAYO CLIN PROC 76:863-864 2001 64 YRS M NR NO NR 3 NA NO

QUININE AM J HEMATOL 70:313-317 2002 NR NR NR NO NR 5 1 NO

QUININE ARCH INTERN MED 164:218-220 2004 43 YRS M NO YES 2 1 NA NO

QUININE ARCH INTERN MED 164:218-220 2004 60 YRS M NO YES 1 1 NA NO

QUININE ARCH INTERN MED 164:218-220 2004 61 YRS F NO NO 1 1 NA NO

QUININE ARCH INTERN MED 164:218-220 2004 47 YRS F NO YES 2 1 NA NO

QUININE BMJ CASE REP 2013 78 YRS M NR NR NR 3 NA NO

QUININIE TRANSFUSION 12: 317-321 1972 22 YRS M YES NO 1 2 NA NO

RANITIDINE BMJ 291:1687 1985 62 YRS M NO NO 0 2 NA NO

RANITIDINE BMJ 292:489 1986 90 YRS F NO YES 0 2 NA NO

RANITIDINE MED J AUST 145:661-662 1986 70 YRS M NR YES NR 3 NA NO

RANITIDINE ANN INTERN MED 106:477 1987 57 YRS M NO NO 0 2 NA NO

RANITIDINE AM J GASTROENTEROL 84:560-562 1989 57 YRS M NO NO 1 2 NA NO

RANITIDINE DICP 23:508-509 1989 51 YRS M NR YES NR 3 NA NO

RANITIDINE ARCH INTERN MED 151:203 1991 NR NR NR NO NR 5 1 NO

RANITIDINE ANN PHARMACOTHER 28:726-729 1994 69 YRS M NR YES NR 3 NA NO

RANITIDINE ANN PHARMACOTHER 28:726-729 1994 82 YRS F NR YES NR 4 NA NO

RANITIDINE BLOOD 92:2359 1998 68 YRS F NO NO 2 2 NA NO

RANITIDINE NEJM 339:1766-1772 1998 41 YRS F NO YES NR 3 NA NO

REPAGLINIDE DIABETES CARE 36: E36 2013 71 YRS M NR NR NR 4 NA NO

RESVERATROL DERMATOL THER 31:E12578 2018 40 YRS F NO NR NR 3 NA YES

RIFABUTIN SCAND J INFECT DIS 43:238 2011 42 YRS F NO YES 0 2 NA NO

RIFAMPICIN INT J DERMATOL 54:819-22 2015 32 YRS M NO NR NR 1 NA YES

RIFAMPIN BMJ 3:24-26 1970 56 YRS M NO YES 2 1 NA NO

RIFAMPIN MED J AUST 2:994 1970 NR NR NR NO NR 5 1 NO

RIFAMPIN BMJ 3:638 1971 NR F NR NO NR 3 NA NO

Page 38: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

RIFAMPIN LANCET 2:103-104 1971 58 YRS M NR NO NR 3 NA NO

RIFAMPIN LANCET 2:491-492 1971 67 YRS M NR NO NR 3 NA NO

RIFAMPIN LANCET 2:167 1971 58 YRS M NR NO NR 5 1 NO

RIFAMPIN NEBR MED J 59:42-43 1974 NR NR NR NO NR 5 1 NO

RIFAMPIN POSTGRAD MED J 56:59-60 1980 37 YRS M NR YES NR 3 NA NO

RIFAMPIN DICP 21:882-884 1987 33 YRS M NR YES NR 3 NA NO

RIFAMPIN CHEST 96:202-203 1989 57 YRS M NO YES 2 1 NA NO

RIFAMPIN DICP 23:382-384 1989 39 YRS M NO YES 0 1 NA NO

RIFAMPIN CHEST 96:202-203 1989 60 YRS F NO YES 1 2 NA NO

RIFAMPIN VOX SANG 57:185-187 1989 17 YRS F NO NO 0 2 NA NO

RIFAMPIN INT J LEPR OTHER MYCOBACT DIS 60:273-274 1992 22 YRS M NO YES 2 1 NA NO

RIFAMPIN J FORMOSAN MED ASSOC 91:475-476 1992 39 YRS M NR NO NR 4 NA NO

RIFAMPIN ANN PHARMACOTHER 28:1304 1994 27 YRS M NO YES 3 2 NA NO

RIFAMPIN TUBER LUNG DIS 77:558-562 1996 34 YRS F NO YES 2 1 NA NO

RIFAMPIN JAPI 44:359-360 1996 44 YRS F NO YES 2 2 NA NO

RIFAMPIN LEPROSY REV 67:229 1996 32 YRS M NO YES NR 4 NA NO

RIFAMPIN TUBER LUNG DIS 77:558-562 1996 60 YRS F NO NO NR 4 NA NO

RIFAMPIN TUBER LUNG DIS 77:558-562 1996 43 YRS F NO YES NR 4 NA NO

RIFAMPIN BR J HAEMATOL 110:907 2000 28 YRS M NR NO NR 2 NA NO

RIFAMPIN BLOOD 95:1988 2000 66 YRS F NO NO 2 3 NA NO

RIFAMPIN IND MED ASSOC J 3:536 2001 40 YRS F NR NO NR 4 NA NO

RIFAMPIN INDIAN J TUBERC 54:94-6 2007 35 YRS F NO NO 3 1 NA NO

RIFAMPIN CLIN APPL THROB HEMOST 13:329-33 2007 6 YRS F NO NR 0 5 1 NO

RIFAMPIN J ASSOC PHYSICIANS INDIA 57:213 2009 32 YRS F NO NO 2 2 NA NO

RIFAMPIN ARCH DIS CHILD 94:734-5 2009 13 YRS F NO NR 0 4 NA NO

RIFAMPIN NEUROL SCI 31:199 2010 68 YRS F NO YES 0 2 NA NO

RIFAMPIN BMJ CASE REP 2012 32 YRS F NO YES 2 1 NA NO

RIFAMPIN EAST J MED 17: 145-8 2012 28 YRS F NO NO 2 2 NA NO

RIFAMPIN EAST J MED 17: 145-8 2012 NR NR NO YES 2 2 NA NO

RIFAMPIN EAST J MED 17: 145-8 2012 35 YRS F NO YES 2 2 NA NO

RIFAMPIN EAST J MED 17: 145-8 2012 18 YRS F YES YES 3 2 NA NO

RIFAMPIN EAST J MED 17: 145-8 2012 35 YRS F NO NO 2 2 NA NO

RIFAMPIN DRUG WATCH 45:405-7 2013 32 YRS M NO YES 2 1 NA NO

Page 39: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

RIFAMPIN MULTIDISCIP RESPIR MED 8:1-3 2013 18 YRS F NR NR NR 1 NA NO

RISPERIDONE GEN HOSP PSYCHIATRY 31:97-8 2009 48 YRS M NO YES 0 2 NA NO

RITUXIMAB LEUKEMIA 15:186-7 2001 60 YRS F NO YES 2 4 NA NO

RITUXIMAB AM J HEMATOL 75:263 2004 57 YRS M NO YES 0 1 NA NO

RITUXIMAB HAEMATOLOGICA 90:ECR23 2005 64 YRS M NO YES 0 2 NA NO

RITUXIMAB HAEMATOLOGICA 90:ECR23 2005 41 YRS M NO YES 0 3 NA NO

RITUXIMAB AM J HEMATOL 78:81 2005 75 YRS M YES YES NR 4 NA NO

RITUXIMAB HAEMATOLOGICA 91:ECR36 2006 3 YRS M NO YES 2 2 NA NO

RITUXIMAB BR J HAEMATOL 135:264-275 2006 44 YRS M NO YES 2 4 NA NO

RITUXIMAB LEUK LYMPHOMA 48:2239-2240 2007 63 YRS M NO NO 0 3 NA NO

RITUXIMAB CANCER INVEST 26:913-5 2008 84 YRS M NO YES 0 5 1 NO

RITUXIMAB MED ONCOL 26:45-8 2009 58 YRS M NO YES 0 1 NA NO

RITUXIMAB AM J HEMATOL 84:247-50 2009 71 YRS F NO YES 0 2 NA NO

RITUXIMAB BR J HAEMATOL 149:804 2010 73 YRS F NO YES 0 1 NA NO

RITUXIMAB AM J HEMATOL 85:146 2010 74 YRS M NO YES 0 5 7 NO

RITUXIMAB CLIN LYMPHOMA MYELOMA LEUK 13: 602-5 2013 76 YRS M NR NR NR 3 NA NO

RITUXIMAB CLIN LYMPHOMA MYELOMA LEUK 13: 602-5 2013 63 YRS F NR NR NR 4 NA NO

RITUXIMAB CLIN LYMPHOMA MYELOMA LEUK 13: 602-5 2013 64 YRS F NR NR NR 4 NA NO

RITUXIMAB CLIN LYMPHOMA MYELOMA LEUK 13: 602-5 2013 60 YRS M NR NR NR 4 NA NO

RITUXIMAB CLIN LYMPHOMA MYELOMA LEUK 13: 602-5 2013 72 YRS M NR NR NR 4 NA NO

RITUXIMAB LEUK LYMPHOMA 54: 2736-7 2013 66 YRS F NR NR NR 5 1 NO

RITUXIMAB BMJ CASE REP 2016218443 2017 39 YRS M NR NR NR 5 7 YES

RITUXIMAB INTERN MED 57:1151-4 2018 74 YRS M NR NR NR 3 NA YES

RIVAROXABAN AM J EMERG MED 36:2 2018 66 YRS M NO YES 2 3 NA YES

ROMIPLOSTIM ANN PHARMACOTHER 49:140-4 2015 65 YRS M NR NR NR 5 1 YES

ROOT PREPARATION AS A TRADITIONAL HERBAL REMEDY

J TROP MED HYG 81: 177 1978 22 YRS M NR NR NR 5 1 NO

ROSIGLITAZONE PLATELETS 17:143-148 2006 66 YRS F NO YES 2 2 NA NO

ROSUVASTATIN SOUTH MED J 103:676-8 2010 65 YRS F NO YES 0 2 NA NO

ROXIFIBAN BLOOD 99:3540 2002 NR NR NO NO 0 2 NA NO

SHO-SAIKO-TO LIVER 20: 491 2000 67 YRS M YES NO 1 1 NA NO

SIMVASTATIN HAEMATOLOGICA 77:357 1992 NR F NO NO 1 2 NA NO

SIMVASTATIN CLIN DRUG INVESTIG 16:172-4 1998 75 YRS F NO YES 0 4 NA NO

Page 40: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

SIMVASTATIN AM J HEM 67(4): 277 2001 77 YRS F NR NR NR 2 NA NO

SIMVASTATIN AM J HEMATOL 67:277 2001 77 YRS F NO NO 0 2 NA NO

SIMVASTATIN ANN HEMATOL 87:773-4 2008 63 YRS M NR NR NR 5 2 NO

SIMVASTATIN J CLIN PHARM THER 38:246-8 2013 78 YRS F NO NO 0 2 NA NO

SIROLIMUS MED LETT DRUGS THER 42:13 2000 NR NR NR NO NR 5 1, NO

SODIUM SALICYLATE J LAB CLIN MED 30: 916 1945 35 YRS M NR YES NR 4 NA NO

SODIUM STIBOGLUCONATE J ANTIMICROB CHEMOTHER 31:187-188 1993 4 YRS M NR NO NR 1 NA NO

SODIUM STIBOGLUCONATE TRANS R SOC TROP MED HYG 87:691 1993 24 YRS M NO NO 0 2 NA NO

SPIRAMYCIN SCAND J INFECT DIS 24:115 1992 25 YRS M NR NO NR 3 NA NO

SPIRONOLACTONE AM J MED SCI 262:68-78 1971 73 YRS M NR NO NR 3 NA NO

STREPTOMYCIN INT J DERMATOL 54:819-22 2015 32 YRS M NO NR NR 4 NA YES

SULFADIAZINE JAMA 122:296 1943 79 YRS F YES YES 3 2 NA NO

SULFADIAZINE AM J MED SCI 205:246-257 1943 60 YRS F NR NO NR 4 NA NO

SULFAMETHOXAZOLE/ PHENAZOPYRIDINE

ANN INTERN MED 104(1):128-9 1986 17 YRS F NO YES 2 2 NA NO

SULFAMETHOXYPYRIDAZINE JAMA 167:457 1958 36 YRS F NO YES 2 2 NA NO

SULFAMETHOXYPYRIDAZINE JAMA 167:457 1958 64 YRS M NO YES 2 5 7 NO

SULFAMETHOXYPYRIDAZINE N Y STATE J MED 59:2034 1959 64 YRS M NO YES 2 2 NA NO

SULFAMETHOXYPYRIDAZINE N Y STATE J MED 63:2554 1963 45 YRS F NO YES 2 2 NA NO

SULFAMTHOXAZOLE TRANSFUSION 55:2738-41 2015 68 YRS M NO YES 2 1 NA YES

SULFAPYRIDINE AM J MED SCI 200:495 1940 60 YRS M YES YES 3 2 NA NO

SULFAPYRIDINE AM J MED SCI 200:495 1940 41 YRS M NO YES 3 2 NA NO

SULFAPYRIDINE W V MED J 36:169-171 1940 57 YRS M NR NO NR 5 1 NO

SULFASALAZINE AM J MED SCI 205:246-257 1943 41 YRS M NR NO NR 3 NA NO

SULFASALAZINE AM J MED SCI 205:246-257 1943 50 YRS F NR NO NR 3 NA NO

SULFASALAZINE AM J MED SCI 205:246-257 1943 62 YRS M NR NO NR 4 NA NO

SULFASALAZINE AM J MED SCI 205:246-257 1943 60 YRS M NR NO NR 4 NA NO

SULFASALAZINE ARCH INTERN MED 140:1122 1980 73 YRS M NR YES NR 4 NA NO

SULFASALAZINE AM J DIS CHILD 135:1070-1072 1981 13 YRS M NR NO NR 5 1,7 NO

SULFASALAZINE ANN INTERN MED 102:277-278 1985 17 YRS M NO NO 1 1 NA NO

SULFASALAZINE ANN RHEUM DIS 44:723-724 1985 61 YRS F NO NO 0 2 NA NO

SULFASALAZINE J PEDIATR GASTROENTEROL NUTR 9:261-263 1989 10 YRS M NO YES 0 5 7 NO

SULFASALAZINE ANN RHEUM DIS 49:798-800 1990 56 YRS F NO NO 0 2 NA NO

Page 41: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

SULFASALAZINE CLIN EXP DERMATOL 19:419-420 1994 19 YRS F NR YES NR 5 2 NO

SULFASALAZINE CLIN RHEUMATOL 17:349 1998 12 YRS F NR NO NR 5 7 NO

SULFATHIAZOLE SOUTHWEST MED 26:49 1942 16 YRS M NO YES 2 2 NA NO

SULFATHIAZOLE JAMA 118:974 1942 37 YRS M NO YES 3 4 NA NO

SULFATHIAZOLE JAMA 122:296 1943 61 YRS M NO YES 3 1 NA NO

SULFATHIAZOLE AM J MED SCI 205:246-257 1943 37 YRS M NR NO NR 3 NA NO

SULFISOXAZOLE JAMA 149:1219 1952 69 YRS M NO YES 3 2 NA NO

SULFISOXAZOLE JAMA 161:1563 1956 64 YRS M NO YES 3 2 NA NO

SULFISOXAZOLE JAMA 161:1563 1956 69 YRS F NO YES 2 2 NA NO

SULFISOXAZOLE AM J HEMATOL 2:65-72 1977 17 YRS F NO YES 1 2 NA NO

SULFISOXAZOLE JAMA 239:2586 1978 19 YRS M NO YES 2 1 NA NO

SULINDAC LANCET 2:594 1980 37 YRS M NO YES 2 2 NA NO

SULINDAC ARTHRITIS RHEUM 24:753-754 1981 25 YRS F NR NO NR 3 NA NO

SULINDAC ANN INTERN MED 104:128-129 1986 67 YRS F NO YES 0 2 NA NO

SUNITINIB ANNALS OF ONCOLOGY 18:1745-7 2007 54 YRS F NR NR 0 5 3 NO

SUNITINIB IRAN J PHARM RES 14:1295-7 2016 64 YRS F YES YES NR 5 3 YES

SURAMIN CANCER 71:851 1993 50 YRS M NO YES 1 2 NA NO

SURAMIN AM J HEMATOL 51:152-157 1996 NR NR NR YES NR 3 NA NO

SURAMIN AM J HEMATOL 51:152-157 1996 NR NR NR YES NR 3 NA NO

SURAMIN AM J HEMATOL 51:152-157 1996 NR NR NR YES NR 3 NA NO

SURAMIN AM J HEMATOL 51:152-157 1996 NR NR NR YES NR 3 NA NO

SURAMIN AM J HEMATOL 51:152-157 1996 54 YRS M NR YES NR 3 NA NO

TAB VACCINE J ASSOC PHYSICIANS INDIA 27:461-2 1979 16 YRS M NO YES 0 5 5 NO

TACROLIMUS PEDIATR TRANSPLANT 9:94-96 2005 5 YRS M NR NO NR 5 7 NO

TACROLIMUS THROMB HAEMOST 94:879-880 2005 46 YRS M YES YES 3 5 1 NO

TACROLIMUS EXP CLIN TRANSPLANT 16:355-6 2018 10 YRS M NR NR NR 5 2,7 YES

TAHINI (PULP SESAME SEEDS) LANCET 352: 618 1998 28 YRS F NO NO 1 1 NA NO

TAMOXIFEN TUMORI 79:231-234 1993 80 YRS F NO YES 0 1 NA NO

TAMOXIFEN AM J CLIN ONCOL 22:529-532 1999 32 YRS F NO NO 0 1 NA NO

TAMOXIFEN MED ONCOL 24:453-454 2007 61 YRS F NO NO 0 2 NA NO

TEICOPLANIN CLIN INFECT DIS 17:927 1993 36 YRS F NO YES 1 1 NA NO

TEICOPLANIN NEPHRON 73:721-722 1996 24 YRS F NR YES NR 4 NA NO

TEMOZOLOMIDE CLIN NEUROL NEUROSURG 112:741-2 2010 30 YRS M YES YES NR 4 NA NO

Page 42: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

TERBINAFINE INT J DERMATOL 37:634-639 1998 25 YRS F NO NO 1 2 NA NO

TERBINAFINE BR J DERMATOL 147:627-628 2002 53 YRS F NO YES 1 2 NA NO

THALIDOMIDE ANN PHARMACOTHER 39:1936-1939 2005 70 YRS F NO YES 1 3 NA NO

THALIDOMIDE AM J HEMATOL 82:855-7 2007 59 YRS M NO YES 2 2 NA NO

THIOGUANINE AM J MED SCI 262:68-78 1971 23 YRS F NR NO NR 5 3 NO

THIOGUANINE AM J GASTROENTEROL 99:1195 2004 36 YRS F NR NO NR 5 3 NO

THIORIDAZINE LANCET 2:1450 1964 48 YRS F NR YES NR 5 7 NO

THIORIDAZINE AUST PAEDIATR J 8:219 1972 NEONATE M NO YES NR 5 1 NO

THIOTEPA J UROL 130:889-891 1983 NR NR NR NO NR 5 3 NO

THIOTHIXENE CAN J PSYCHIATRY 32:149-150 1987 59 YRS F NO YES 0 1 NA NO

THYMIC EXTRACT ANN INTERN MED 129: 797-800 1998 NR NR NR NO NR 3 NA NO

TIAGABINE NEUROLOGY 52:889 1999 42 YRS F NO YES 1 2 NA NO

TICLOPIDINE NEJM 323:1487-1488 1990 67 YRS M NO NO 2 2 NA NO

TICLOPIDINE LANCET 337:774-776 1991 72 YRS M NR NO NR 5 7 NO

TICLOPIDINE LANCET 337:774-776 1991 47 YRS F NO YES 3 5 7 NO

TICLOPIDINE LANCET 337:774-776 1991 72 YRS M YES YES 3 5 7 NO

TICLOPIDINE LANCET 337:774-776 1991 75 YRS M NO YES 3 5 7 NO

TICLOPIDINE ANN PHARMACOTHER 28:1236-1238 1994 83 YRS M NR YES NR 4 NA NO

TICLOPIDINE AUST N Z J MED 27:599 1997 72 YRS M NO NO 1 2 NA NO

TICLOPIDINE NETH J MED 54:73 1999 58 YRS F NO NO 0 2 NA NO

TICLOPIDINE AM J CARDIOL 83:138 1999 73 YRS M NR NO NR 5 7 NO

TICLOPIDINE AM J CARDIOL 83:138 1999 57 YRS F NR NO NR 5 7 NO

TIROFIBAN BLOOD 100:2071-6 2002 65 YRS M NO YES 0 3 NA NO

TIROFIBAN BLOOD 100:2071-6 2002 78 YRS M NO YES 0 3 NA NO

TIROFIBAN BLOOD 100:2071-6 2002 78 YRS F NO YES 0 3 NA NO

TIROFIBAN BLOOD 100:2071-6 2002 64 YRS M YES YES 3 5 1 NO

TIROFIBAN CARDIOVASC DRUGS THER 18:503-505 2004 63 YRS M NO YES 0 1 NA NO

TIROFIBAN AM J HEMATOL 77:67-71 2004 47 YRS F NO YES NR 2 NA NO

TIROFIBAN AM J HEMATOL 77:67-71 2004 67 YRS M NO YES NR 2 NA NO

TIROFIBAN AM J HEMATOL 77:67-71 2004 72 YRS F NO YES NR 2 NA NO

TIROFIBAN ANGIOLOGY 56:351-355 2005 80 YRS M NO YES NR 3 NA NO

TIROFIBAN J THROMB HAEMOST 3:1109-1110 2005 67 YRS M NO YES NR 3 NA NO

TIROFIBAN J THROMB HAEMOST 3:1109-1110 2005 80 YRS M NO YES NR 3 NA NO

Page 43: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

TIROFIBAN ACTA CARDIOL 61:577-9 2006 57 YRS M NO YES 0 2 NA NO

TIROFIBAN J THROMB THROMBOLYSIS 22:77-78 2006 58 YRS M NO YES 0 2 NA NO

TIROFIBAN PHARMACOTHERAPY 26:423-427 2006 51 YRS M NO YES NR 3 NA NO

TIROFIBAN J THROMB THROMBOLYSIS 24:59-64 2007 62 YRS M NO YES 0 2 NA NO

TIROFIBAN J THROMB HAEMOST 5:1068-70 2007 57 YRS M NO YES NR 3 NA NO

TIROFIBAN ANN THORAC SURG 87:629-31 2009 63 YRS M NO YES 3 3 NA NO

TIROFIBAN TEX HEART INST J 36:55-7 2009 58 YRS M NO YES 3 3 NA NO

TIROFIBAN TEX HEART INST J 37:109-12 2010 50 YRS M NO YES NR 3 NA NO

TIROFIBAN INT J HEMATOL 96: 370-5 2012 73 YRS M NO YES 2 2 NA NO

TIROFIBAN INT J HEMATOL 96: 370-5 2012 47 YRS M NO YES NR 2 NA NO

TIROFIBAN ASIAN CARDIOVASC THORAC ANN 21: 74-6 2013 55 YRS M NR NR NR 3 NA NO

TIROFIBAN PLATELETS 2013 87 YRS F NR NR NR 3 NA NO

TIROFIBAN PLATELETS 26:197-8 2015 40 YRS M NO YES 0 3 NA YES

TIROFIBAN EXP THER MED 12:1177-80 2016 68 YRS M NO YES NR 2 NA YES

TIROFIBAN INT J CARDIOL 206:93-4 2016 66 YRS M YES YES 3 5 1 YES

TMN-1 J ALTERN COMPLEMENT MED 16: 1221-12224 2010 52 YRS F NR NR NR 3 NA NO

TOBRAMYCIN DICP 12:682 1978 59 YRS M NR YES NR 3 NA NO

TOLBUTAMIDE JAMA 169:1468 1959 69 YRS M YES YES 0 5 7 NO

TOLBUTAMIDE J PEDIATR 77:457-458 1970 NR NR NR NO NR 5 1 NO

TOLMETIN VA MED 109:171 1982 52 YRS F NO YES 2 1 NA NO

TOLMETIN ARTHRITIS RHEUM 25:1144-5 1982 4 YRS F NO NO 1 2 NA NO

TOSUFLOXACIN J DERMATOL 34:465-7 2007 69 YRS M NO YES 0 4 NA NO

TRANILAST J DERMATOL 25:706-709 1998 17 YRS M NO YES 1 2 NA NO

TRANYLCYPROMINE J CLIN PSYCHOPHARMACOL 16:264 1996 39 YRS M NR NO NR 4 NA NO

TRASTUZUMAB NEW ENG J MED 357:1869-71 2007 54 YRS F NO NO 2 2 NA NO

TRASTUZUMAB CLIN BREAST CANCER 8:285-6 2008 56 YRS F NO NO 0 2 NA NO

TRASTUZUMAB ANN ONCOL 20:1607-8 2009 37 YRS F NO YES 0 1 NA NO

TRASTUZUMAB ANN ONCOL 20:1606-7 2009 54 YRS F NO YES 0 5 1 NO

TRASTUZUMAB ANN ONCOL 21:668-9 2010 NR F NO YES 2 4 NA NO

TRASTUZUMAB MED SCI MONIT 17:CS85-7 2011 56 YRS F NR YES NR 4 NA NO

TRASTUZUMAB BMC RES NOTES 6:1-3 2013 70 YRS F NO YES 2 2 NA NO

TRASTUZUMAB J CLIN PHARM THER 41:563-5 2016 70 YRS F NR YES 0 5 3 YES

Page 44: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

TRIMETHOPRIM/ SULFAMETHOXAZOLE

JAMA 122:168 1943 23 YRS F NR YES NR 4 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

JAMA 122:168 1943 40 YRS F NR YES NR 4 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J CLIN PATHOL 6:320 1953 50 YRS M NR YES NR 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PRACTITIONER 202:553-554 1969 24 YRS F NO YES 3 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

POSTGRAD MED J 45:46-51 1969 NR NR NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 2:754 1970 56 YRS M NO NO 0 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 2:200 1970 26 YRS M NR NO NR 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 2:200 1970 40 YRS F NR NO NR 4 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J CLIN PATHOL 23:392-396 1970 NR NR NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 2:754 1970 60 YRS M NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 1:769 1971 38 YRS M NO YES 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

IND PRACTITIONER 24:153-154 1971 20 YRS M NR YES NR 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

N Z MED J 78:433-5 1973 12 YRS F NO NR 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

MED J AUST 2:468 1973 86 YRS F NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

N Z MED J 78:433-5 1973 89 YRS F NO NR NR 5 2,7 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

N Z MED J 78:433-5 1973 77 YRS M NO NR NR 5 2,7 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J INFECT DIS 132:630 1975 NR NR NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

BMJ 2:898 1979 NR NR NR NO NR 5 2 NO

Page 45: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

TRIMETHOPRIM/ SULFAMETHOXAZOLE

AUST N Z J MED 10:54-55 1980 35 YRS F NO YES 1 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

ANN INTERN MED 93:560-562 1980 NR NR NR NO NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SOUTH MED J 74:640-641 1981 3 YRS M NO YES 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

AM J DIS CHILD 135:1094-5 1981 NR NR NR NR NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

WIS MED J 81:21-23 1982 54 YRS F NO NO 3 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SOUTH MED J 76:503 1983 4 YRS M NO YES 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SOUTH MED J 76:503 1983 63 YRS F NR YES NR 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

JAMA 252:3257-3260 1984 70 YRS F NR NO NR 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

W V MED J 80:219-220 1984 73 YRS F NO YES 3 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

ANN INTERN MED 104:128-129 1986 17 YRS F NO YES 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

TRANSFUSION 27:262 1987 68 YRS F NO YES 1 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

TRANSFUSION 27:262-5 1987 68 YRS M NR NR NR 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

TRANSFUSION 27:262-5 1987 74 YRS F NR NR NR 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

INT J ORAL MAXILLOFAC SURG 18:206-207 1989 72 YRS M NO YES 3 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J ASSOC PHYSICIANS INDIA 37:479 1989 15 YRS F YES YES 3 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

AM J HEMATOL 43:329-330 1993 21 YRS F NO YES 2 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

ANN PHARMACOTHER 27:1139-1140 1993 54 YRS F NO YES 1 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

BLOOD 82:1683 1993 30 YRS M NO YES 1 2 NA NO

Page 46: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SOUTH MED J 87:948-950 1994 27 YRS F NO YES 0 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SOUTH MED J 87:948-950 1994 35 YRS F NO YES 0 2 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

EUR J PEDIATR 158:S209-210 1999 7 YRS F NO YES 2 5 1 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

SEMIN HEMATOL 37:229-238 2000 70 YRS F NR NO NR 4 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PSYCHIATRIC SERVICES 52:111-112 2001 47 YRS F NR NO NR 5 1,7 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

ANN PHARMACOTHER 36:78-82 2002 54 YRS F NO YES 2 3 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J INFECT 51:E49-52 2006 40 YRS M YES YES 0 5 7 NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

AM J TRANSPLANT 10:943-6 2010 42 YRS M NO YES 2 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

AM J TRANSPLANT 943-6 2010 42 YRS M NO NO NR 1 NA NO

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PEDIATR BLOOD CANCER 62:922-23 2015 15 YRS F NO YES 1 3 NA YES

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PEDIATR BLOOD CANCER 62:922-23 2015 7 YRS F NO YES 1 3 NA YES

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PEDIATR BLOOD CANCER 62:922-23 2015 10 MOS M NO YES 1 3 NA YES

TRIMETHOPRIM/ SULFAMETHOXAZOLE

PRESCRIRE INT 24:185 2015 NR NR NR NR NR 5 1 YES

TRIMETHOPRIM/ SULFAMETHOXAZOLE

J INVESTIG MED 65:485 2017 29 YRS M NO YES 2 2 NA YES

TRIMETHOPRIM/ SULFAMETHOXAZOLE

TRANSFUSION 57:2937-41 2017 61 YRS F NR NR NR 5 7 YES

VALPROIC ACID BMJ 2:179 1976 NR NR NR NO NR 5 1,3 NO

VALPROIC ACID BMJ 23:981 1976 6 YRS M NO NO 0 5 3 NO

VALPROIC ACID BMJ 2:1683-1684 1978 6 YRS M NR NO NR 5 1,3 NO

VALPROIC ACID DEV MED CHILD NEUROL 20:487-490 1978 7 YRS F NR NO NR 5 3 NO

VALPROIC ACID LANCET 1:670-671 1978 CHILD M NR NO NR 5 3 NO

VALPROIC ACID BRAIN DEV 1:319-322 1979 6 YRS M NR NO NR 5 3 NO

Page 47: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

VALPROIC ACID CAN MED ASSOC J 125:63-64 1981 4 YRS F NR NO NR 5 3 NO

VALPROIC ACID CAN MED ASSOC J 125:63-64 1981 2.5 YRS F NO YES 0 5 3 NO

VALPROIC ACID ARCH DIS CHILD 57:681-684 1982 NR NR NR NO NR 5 1,3 NO

VALPROIC ACID CAN MED ASSOC J 126:358-359 1982 10 YRS F NR NO NR 5 1,3,7 NO

VALPROIC ACID J KY MED ASSOC 80:213-215 1982 5 YRS M NO YES 0 5 3 NO

VALPROIC ACID EUR J PEDIATR 153:378-380 1994 14 YRS M NO YES 3 5 3 NO

VALPROIC ACID J CLIN PSYCHIATRY 58:125 1997 48 YRS F NO YES NR 5 3 NO

VALPROIC ACID J PEDIATR 130:1001-1003 1997 3 MOS M NO YES 0 5 3 NO

VALPROIC ACID ANN CLIN PSYCHIATRY 10:35-37 1998 57 YRS F NO NO NR 5 3 NO

VALPROIC ACID J CLIN PSYCHIATRY 61:680 2000 45 YRS M NR NO NR 5 2,3 NO

VALPROIC ACID EPILEPSIA 43:451-454 2002 2 YRS M NO YES 0 5 1,3,7 NO

VALPROIC ACID J PEDIATR HEMATOL ONCOL 24:589-590 2002 10 YRS F NO YES 0 5 3 NO

VALPROIC ACID PHARMACOLOGY 70:57-58 2004 4 YRS M NO YES NR 5 3 NO

VALPROIC ACID J CHILD ADOLESC PSYCHOPHARMACOL 15:1011-1014

2005 16 YRS F NR NO NR 5 2,3 NO

VALPROIC ACID J CHILD ADOLESC PSYCHOPHARMACOL 15:1011-1014

2005 10 YRS F NO NO 0 5 2,3 NO

VALPROIC ACID EPILEPSIA 47:1136-43 2006 8 YRS M NO YES 2 5 3 NO

VALPROIC ACID PSYCHOSOMATICS 56:410-3 2015 39 YRS M NO NR NR 5 3 YES

VANCOMYCIN LANCET 1:932 1985 48 YRS F NO YES 1 2 NA NO

VANCOMYCIN BLOOD 75:518-523 1990 73 YRS F NR NO NR 4 NA NO

VANCOMYCIN BLOOD 75:518-523 1990 31 YRS M NR NO NR 4 NA NO

VANCOMYCIN ARCH INTERN MED 151:995-996 1991 54 YRS M NO YES 0 1 NA NO

VANCOMYCIN ARCH INTERN MED 152:413-414 1992 NR NR NR NO NR 5 1 NO

VANCOMYCIN VOX SANG 73:49-51 1997 71 YRS F NO YES 3 1 NA NO

VANCOMYCIN ANN PHARMACOTHER 31:315-318 1997 36 YRS F NR NO NR 3 NA NO

VANCOMYCIN AM J HEMATOL 60:249-250 1999 72 YRS F NO YES 0 2 NA NO

VANCOMYCIN AM J HEMATOL 62:122-123 1999 72 YRS F NO YES 0 2 NA NO

VANCOMYCIN PHARMACOTHERAPY 23:1195-1198 2003 50 YRS M NO YES 3 1 NA NO

VANCOMYCIN PDI 23:506-508 2003 45 YRS M NO YES 2 3 NA NO

VANCOMYCIN J EMERG MED 30:99-100 2006 2 YRS M NO YES 0 2 NA NO

VANCOMYCIN AM J HEMATOL 82:1122 2007 56 YRS F NO YES 2 1 NA NO

VANCOMYCIN PLATELETS 19:379-83 2008 61 YRS M NO YES 2 2 NA NO

Page 48: For definitions of bleeding, score and inclusion/exclusion ... Table Individual 2018.pdfactinomycin d am j ther 23:e594-6 2016 3.5 yrs f no yes nr 5 3 yes acyclovir am j emerg med

DRUG NAME CITATION YEAR AGE SEX DEATH HOS BL SC EX NEW 2018

VANCOMYCIN PHARMACOLOGY 82:285-6 2008 25 DAYS M NO YES 0 3 NA NO

VANCOMYCIN TRANSFUS MED 21:137-9 2011 67 YRS M YES YES NR 2 NA NO

VANCOMYCIN PHARMACOTHERAPY 32: E321-5 2012 41 YRS M NR NR NR 3 NA NO

VANCOMYCIN J INTERV CARD ELECTROPHYSIOL 38:143-5 2013 54 YRS F NR NR NR 3 NA NO

VANCOMYCIN SPEC CARE DENTIST 37:38-42 2017 57 YRS F NO YES NR 2 NA YES

VANCOMYCIN DRUG SAF 40:49-59 2017 NR NR NR NR NR 5 1 YES

VANCOMYCIN BMJ CASE REP 2014208192 2015 67 YRS M NO YES NR 3 NA YES

VANCOMYCIN/PIPERACILLIN J CLIN ANESTH 27:602-5 2015 62 YRS F NO YES NR 1 NA YES

VITAMIN A PALMITATE BLOOD 99: 2017-2022 2002 0 YRS M YES NO 3 2 NA NO

WALNUT (ENGLISH) LANCET 379: 776 2012 70 YRS M NO NO 2 1 NA NO

ZIDOVIDINE ARCH DERMATOL 127:1068-1069 1991 NR NR NR NO NR 5 1 NO

ZOLEDRONIC ACID BMJ CASE REP 2015213786 2016 70 YRS F NO YES NR 2 NA YES